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1.1 Abstract 
As main cause of the common cold, Human Rhinoviruses are responsible for the 
expense of around $40 billion each year alone in the US for lost working days and medical 
treatment. Prevention of the infection is difficult due to the more than 100 serotypes. Most 
employ either the major group receptor ICAM-1 or the minor group receptor from the 
LDLR family for attachment to the host cell. Upon binding to the receptor, the cell engulfs 
a vesicle containing the virus particle. These early endosomes mature to late endosome 
concomitant to decreasing the pH. At pH below 5.6 the capsid of HRV undergoes 
structural changes which trigger the (+)ss-RNA release and transfer across the endosomal 
membrane into the cytoplasm of the host cell. First, the viral protein (VP) 4, one of the 
four structural proteins of the icosahedral capsid, is lost and the N-terminus of VP1 is 
externalized to form the hydrophobic 135S subviral particle. Ejection of the RNA results in 
80S subviral particle. The exact mechanism of the RNA release and transfer across the 
membrane is not known. For minor group viruses the implication of VP4 and the N-
terminus of VP1 in pore formation is discussed, data for major group viruses rather point 
at disruption of the membrane. So far, neither was demonstrated visually. High resolution 
microscopic imaging of viral particles and their attachment site during the process of RNA 
transfer is difficult with cells, therefore liposomes were developed as model for 
endosomes.  
To detect RNA transfer across the membrane, a reverse transcription kit was 
encapsulated for immediate transcription (RT) of RNA into cDNA which could 
subsequently be amplified by PCR. We termed these functional liposomes 
“nanocontainers” and decorated them with receptor and virus prior to triggering the RNA 
transfer via a pH of 5.4. For tight attachment of HRV2, a minor group virus, a 
recombinant VLDLR was bound via a His6-tag to the lipid Ni-DGS-NTA. The study of 
major group viruses requires a recombinant ICAM-1 receptor which was cloned for 
expression in eukaryotic cells in the course of the present diploma thesis. Disruption of the 
nanocontainer membrane either due to added detergent as a control or high virus 
concentration caused leakage and subsequently a decreased RNA transcription efficiency. 
This finding also points at RNA transfer through a pore in the membrane. The virus/lipid 
ratio yielding the highest cDNA transcription efficiency was determined at 3.4 x 10-6. At 
this composition, the potentiating effect of calcium and the inhibiting effect of the antiviral 
drug amiloride on the RNA transfer efficiency could be elucidated.  
The nanocontainer system is a fast and easily to manipulate model of viral infection 
and might be applicable to all minor and major group HRVs once the ICAM-1 receptor is 
expressed. 
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1.2 Zusammenfassung (german abstract) 
Obwohl das Humane Rhinovirus hauptsächlich gewöhnliche Erkältungen auslöst, 
verursacht es durch seine hohe Prävalenz alleine in den USA Kosten von $40 Milliarden 
pro Jahr für Arbeitsentgang und medizinische Behandlung. Immunität ist kaum möglich, 
da mehr als 100 Serotypen zirkulieren, die man nach ihrem Bindungsprotein in major 
group und minor group HRV einteilt, die ICAM-1 bzw. ein Mitglied der LDLR superfamily 
als Rezeptor zur Bindung an die Wirtszelle benutzen. Bindet der Virus an seinen Rezeptor, 
wird der Komplex in einem Membranvesikel internalisiert, das während der Reifung zu 
einem späten Endosom den pH Werts unter 5.6 erniedrigt. Diese Azidifizierung löst im 
ikosaedrischen Capsid des HRV den Verlust des strukturellen viralen Proteins (VP) 4 und 
die Externalisierung des N-terminus von VP1 aus, was zu einem hydrophoben 135S 
subviralen Partikel führt. Diese Capsidbestandteile formen möglicherweise eine Pore in 
der Membran, durch die die (+)ss-RNA in das Cytoplasma der Wirtszelle geschleust 
werden kann; zurück bleibt das leere, nicht infektiöse 80S subvirale Partikel. Im Fall der 
major group HRVs wird auch ein Zerreißen der Membran diskutiert. Der genaue Hergang 
des RNA Transfers konnte in der Zelle bisher nicht visuell dargestellt werden. Deshalb 
wurden Liposomen als ein Modell der späten Endosomen hergestellt und mit einer 
Reaktionsmischung für reverse Transkription (RT) gefüllt um die Detektion der 
transferierten RNA zu ermöglichen.  
Die dadurch entstehenden „Nanocontainer“ wurden mit einem rekombinanten VLDLR, 
der über ein His6-Tag an das Lipid Ni-DGS-NTA binden kann, dekoriert, die so eine feste 
Bindung zwischen Virus und Nanocontainer herstellen konnten. Durch einen pH-Wert 
von 5.4 wurde der Transfer der viralen RNA von HRV2, einem minor group Virus, in das 
Lumen der Nanocontainer ausgelöst und konnte vor Ort in cDNA umgekehrt transkribiert 
werden, die durch eine nachfolgende PCR vervielfacht und somit sichtbar gemacht werden 
konnte. Um auch major group HRVs untersuchen zu können, wurde im Laufe der 
vorliegenden Arbeit auch ein rekombinanter ICAM-1 Rezeptor kloniert, der in 
eukaryotischen Zellen exprimiert werden kann. Das geeignetste Verhältnis von Virus zu 
Lipid wurde mit 3.4 x 10-6 gefunden. Höhere Viruskonzentrationen führten zur Zerstörung 
der Membran, genauso wie als Kontrolle zugegebenes Detergens, wodurch der RT Mix 
verdünnt wurde und keine cDNA mehr transkribierte. Dies deutet auch wieder auf die 
Bildung einer Pore für den Transfer von minor group RNA hin. Mit dem Nanocontainer 
System wurde ein RNA Transfer verstärkender Effekt von Calcium und ein gegenteiliger 
von dem antiviral wirkenden Molekül Amiloride gefunden.  
Sobald der neu klonierte ICAM-1 Rezeptor exprimiert ist, könnte das Nanocontainer 
System ein einfach abzuänderndes Modell für den RNA Transfer von allen HRVs sein.  
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2 Introduction 
2.1 Picornaviridae 
2.1.1 Classification 
Currently two modes of virus classification are in use. The first is the Baltimore 
classification. It was developed in 1971 by David Baltimore [1] on the basis of viral 
genomes and the mode of replication. All viruses are classified into seven groups, named 
in Roman numerals. Their shared genome implies also a common mode of infection and 
replication, allowing a constricted transmission of investigational data between species 
within one class. For replication in a host cell, it is mandatory to transcribe the viral 
genome, no matter in what form it enters the cell, into mRNA, a positive stranded RNA 
which can be used for translation. Figure 2-1 depicts the seven viral groups according to 
their genome class and their intermediate steps on the way to produce mRNA.  
 
Figure 2-1. Baltimore classification scheme of viruses. White background signifies the viral 
genome, double stranded (ds) or single stranded (ss) and the directionality (+ or -) is given, 
reverse transcription (RT) as replication strategy noted. Light gray background indicates the 
necessary intermediate steps of genome replication until mRNA (dark grey) is produced which 
serves as universal template recognized by the host cellular replication and translation 
machinery. 
Picornaviruses belong to the group IV, comprising all positive sensed single stranded RNA 
viruses. They need one intermediate step, negative single stranded RNA from which more 
positive stranded RNA is transcribed. 
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 Further classification and taxonomy of viruses is taken care of by the International 
Committee on Taxonomy of Viruses (ICTV) (see Figure 2-2). According to the decisions 
made by the ICTV, the family picornaviridae belongs to the higher order of picornavirales, 
also including the families dicistroviridae, iflaviridae, marnaviridae which are all animal 
infecting viruses, and secoviridae, which include the subfamily comovirinae and comprises 
all plant picornaviruses. All families share certain characteristics; since similarities in 
genome structure are a principal indicator for classification, sequencing provides 
additional proof and often changes of classification. At present, the family Picornaviridae 
comprises 12 genera, one of them is the genus enterovirus, others are aphthovirus (the 
species Foot-and-mouth disease virus belongs to that genus) or hepatovirus (holding the 
species Hepatits A virus). The genus enterovirus comprises 10 virus species, including 
Human Enterovirus C, which was formerly known as Poliovirus, and all serotypes of 
Human Rhinovirus, organized as the species Human Rhinovirus A, Human Rhinovirus B 
and Human Rhinovirus C. Other enterovirus species are Bovine enterovirus,  Human 
enterovirus A,  Human enterovirus B,  Human enterovirus D,  Porcine enterovirus B,  
Simian enterovirus A. See  Figure 2-2 for an overview of ICTV Picornaviridae 
classification. 
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Figure 2-2. Viral 
classification 
according to the 
ICTV (of July 
2010) with 
particular focus on 
the order 
picornaviridae. 
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2.1.2 Morphology 
Picornaviridae are small viruses with 27-30 nm diameter of their non-enveloped 
icosahedral capsid. An icosahedron has 20 identical equilateral triangular faces (eikosi is 
Greek for twenty). In picornaviruses, the outer capsid is made up by three different 
proteins, the viral proteins 1-3 (VP 1-3). Although their amino acid sequences are 
different, they share the general structure: each viral protein consists of eight antiparallel 
β-sheets which together form a β-barrel. One copy each of VP 1-3 form a triangular 
protomer, which consequently consists of 3 β-barrels. A triangulation number (T) = 3 
capsid consists of 180 structurally identical β-barrels, and although picornaviral capsids 
look similarly, they are formed by 3 different proteins and hence exhibit P = 3 (pseudo T = 
3). In total, the picornaviral capsid is composed of 60 protomers. Five of these protomers 
are located around a 5 fold axis (see Figure 2-3 for icosahedron assembly).  
 
 
Figure 2-3. Assembly of the icosahedral picornavirus capsid. (A) Each protomer consists of one 
copy each of VP1-3. Five of these protomers form a pentamer around a fivefold axis (5x). Taken 
from Hogle and Racaniello [2] (B) Top view of one of the 12 pentamers of the icosahedron, 
which contains a cation, probably Ca2+, in the middle. A canyon (dark grey) encircles the axis. 
Structures supposedly playing a role in viral uncoating are indicated for one protomer: VP1 GH 
loop, VP3 N-terminus and part of VP4. Also a drug binding to the canyon and inhibiting viral 
infection is shown. From Giranda et al.[3]. 
A binding site for divalent ions, most probably calcium, has been observed in this central 
position, supposedly playing a role in virion stabilization [4]. Each protomer features a 
canyon which encircles the fivefold axes. It is 15 Å deep and 12 Å wide at its narrowest 
point. The canyon is the binding site of several receptors. The outer surface of the capsid is 
made up by the C-termini of only VP1, 2 and 3, the fourth and smallest structural protein 
VP4 is inside the capsid. The N-termini of VP3 form a β-cylinder at the fivefold axis. This 
structure is surrounded by the N-termini of VP4 and VP1, the interaction is mediated by a 
myristic acid which is covalently linked to the terminus of VP4 [5]. This myristoylation is 
not only necessary for correct assembly, it also plays a role in infectivity.  
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Inside the capsid, the RNA is tightly packaged to fit into the small space. Picornaviral 
RNA is about 7500 nucleotides (nt) in length. In contrast to eukaryotic mRNA, the 5’ end 
of the picornaviral RNA is covalently linked to a peptide, the viral protein genome-linked 
(VPg). This protein functions as a primer for RNA replication. The 3’ end is formed of a 
polyA-tail - like mammalian mRNA - although it is an actual part of the viral genome and 
not added posttranscriptionally like in mammalian mRNA. Both sides of the RNA contain 
an untranslated region (UTR), the longer one with around 600-1200 nt on the 5’ end and 
a shorter 50-100 nt at the 3’ end. 
2.1.3 Replication pathway 
The viral life cycle of Picornaviridae has been studied very well in poliovirus, therefore 
it often serves as model for this virus family. Figure 2-4 presents a schematized summary 
of the poliovirus life cycle as an example for picornaviruses.  
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Figure 2-4. Picornaviral life cycle depicted by the example of poliovirus. The native virion 
attaches to its receptor on the plasma membrane of the host cell, which internalizes the 
particle into an early endosome. Upon maturation to the late endosome, the pH inside the 
vesicle is decreased, which causes the transfer of the viral RNA into the cytoplasm of the cell, 
either through a pore or via disruption of the endosomal membrane. The positive sense viral 
RNA can be translated and the resulting polyprotein proteolytically cleaved into its mature 
viral proteins. One of the proteins is viral replicase which uses the viral RNA as a template for 
RNA replication with a negative stranded RNA as an intermediate. Viral RNA with attached 
VPg on the 5’ end can be packaged in the procapsid consisting of the structural proteins VP1, 
VP3 and VP0, the latter one is cleaved to VP2 and VP4 for full maturation of the virion. Viral 
proteins also shut off the translation of cellular proteins and lyse the host cell membrane, 
releasing the new viral particles. From Basic Virology [6, p. 238]. 
 
Picornaviruses abuse different cell surface molecules as receptors and co-receptors for 
attachment to the host cell surface. The picornaviral RNA is either directly transferred 
across the cell membrane, or the virion is first internalized into endosomes and the RNA 
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transferred across the endosomal membrane into the cytoplasm of the host cell [5] p. 810. 
The (+) RNA is translated, using a special region within the 5’ UTR, the internal ribosome 
entry site (IRES), for ribosome recruiting. The translation termination signal is close to 
the 3’ end, allowing for the translation of a single large polyprotein. This polyprotein is the 
precursor of all viral proteins. It is at first cleaved intramolecularly by two viral proteases 
to produce 3 large precursor proteins: P1-3. P1 is further cleaved into VP1, VP3 and VP0, 
the latter further into VP2 and VP4 during virion maturation. All non-structural viral 
proteins are derived from P2 and P3, including the viral replicase (P3D, an RNA-
dependent RNA polymerase), VPg and host cell modulating proteins and enzymes. 
Already at an early stage of infection the virus shuts off the translation of host mRNA by 
proteolytic digestion of the translation initiation factor eIF-4G, which functions in 
ribosomal recognition of 5’ capped mRNA. Picornaviruses do not need the 5’ cap for 
translation initiation, but rather use the IRES instead; all resources of the host cell are 
exploited for the translation of viral proteins.  
P3D replicates the RNA genome. It has quite a high error rate compared to DNA 
polymerases (one mutation per 104-105 nt as compared to 107-109 nt for Pol II), not only 
because of the low specificity of the replicase, but also because of the absence of a proof-
reading function. The high error rate causes a high variability in progeny virions, making 
fast adaption to the surroundings possible. It is also a way of escape from the immune 
system of the host or specially designed drugs.  
Replication needs uridylylated VPg as a primer. Partly cleaved precursor proteins from 
P2 and P3 bind to the template RNA strand, either at the polyA-tail or to the origin of 
replication internal (oriI) [7], one of them being the replicase which catalyzes the 
attachment of VPg or its uncleaved precursor. In the presence of UTP, the Tyr-3 hydroxyl 
of VPg is used as a nucleophile to form VPg-pU, the 3’-OH which, in turn, serves as the 
nucleophile to form VPg-pUpU [7]. The uridylylated VPg is moved to the 3’ end of the 
template RNA strand and acts as a primer for the viral replicase to start RNA transcription 
of either a positive or negative strand. Negative sense strands serve as template for further 
positive sense strands, which in turn are used for translation of more viral proteins when 
the VPg is cleaved off, or are packaged with an attached VPg. The procapsid, consisting of 
equimolar quantities of VP1, 3 and VP0, encapsulates the (+)ssRNA-VPg and matures to 
the full virion via cleavage of VP0 to VP2 and VP4. Mature virions accumulate in the 
cytoplasm of the host cell until the cell membrane is lysed, releasing the progeny virions. 
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2.2 Human Rhinovirus 
2.2.1 Pathogenesis 
The word rhino is Greek for nose. The name was chosen because human rhinoviruses 
infect the polarized epithelial cells of the upper and to some extent also the lower airways 
of humans. Ciliated cells, which hardly express any ICAM-1 in the absence of 
inflammation, are rarely infected. Estimated 50% of all mild infections of the upper 
respiratory tract are caused by rhinoviruses, they also provoke more severe diseases like 
exacerbating asthma or chronic obstructive pulmonary disease. Due to the variety of 
serotypes it is difficult to develop immunity, resulting in a high prevalence and many lost 
working / school days. Although common cold infections are generally mild, the sheer 
number of infections lead to around $40 billion spent alone in the USA on medication and 
loss of working time per year [8]. The large number of serotypes and variability within 
them also makes it difficult to develop medication. Rhinoviruses are spread via aerosols 
and smear infections and can be stable at ambient temperatures on commonly touched 
surfaces like door handles for days. About 1-4 days after infection, the typical symptoms 
become evident: discharging or blocked nasal passages, accompanied by a general 
malaise, cough, sore throat, edema of the connective tissue etc at the peak of the infection. 
The nasal secretion contains a high virus titer. The direct tissue destruction through 
replication of virus and lysis of its host cell is actually quite marginal; the symptoms 
experienced are rather caused by the immune reaction of the infected cells, increased by 
released histamine. The first defense reaction of infected cells includes production of 
interferons which stimulate other cells to produce antiviral proteins (they break down 
viral RNA and inhibit elongation during protein translation) and class I MHC molecules 
and activate the immune system to kill infected cells. Specific immune response includes 
the production of antibodies, IgA is secreted from the nasal mucosa and provides 
immunity to the infecting HRV serotype for 1-2 years. As mentioned, this immunity does 
not prevent further common cold infections caused by one of the many other serotypes. 
Treatment is normally restricted to relieving the symptoms and not directly antiviral. 
Other viruses causing diseases with similar symptoms include parainfluenzaviruses, 
coronaviruses and enteroviruses. 
2.2.2 Taxonomy 
Currently, there are 106 HRV serotypes known. They are categorized into Human 
Rhinovirus A, B and C, according to the results of genetic typing of a nucleotide sequence 
between VP4 and VP2. There are 74 HRV-A, 25 HRV-B and 7 HRV-C serotypes 
acknowledged right now, although there are more to expect. HRV 87 showed closer 
relationship to the species human enterovirus D than to any other HRV serotype and was 
RNA transfer of HRV through model membranes 
    Introduction 
diploma thesis by Nena M. Matscheko   - 13 - 
 
therefore reclassified as human enterovirus 68 [9]. The long time distinction of 
rhinoviruses and enteroviruses based on their acid stability/lability has been superseded 
by this new classification and the taxonomical grouping of picornaviruses was revised. The 
distinct genera enterovirus and rhinovirus were grouped together as a single genus with 
the name enterovirus. 
Another often used classification founds on the employed receptor. Sixty-two HRV-A 
and all HRV-B use ICAM-1, which is therefore called the major group receptor; the 
remaining 12 HRV-A bind to the minor group receptor which is a member of the low-
density lipoprotein (LDL) receptor family: LDLR, very low-density lipoprotein receptor 
(VLDLR) or lipoprotein receptor related protein (LRP). Also heparan sulphate can be used 
by some major group viruses for attachment. HRV-C has only been recognized as a species 
recently and its receptor(s) have not yet been described. 
Depending on their stage of uncoating, subviral particles have been given particular 
names. The native HRV particle sediments at 150 Svedberg (S) upon centrifugal 
sedimentation in a sucrose density gradient and is therefore also called 150S particle. 
During infection, the particle undergoes structural changes, in a first step the amphiphilic 
N-terminus of VP1 is externalized and the capsid protein VP4 is lost. These molecules are 
believed to insert into host cell membranes, ensuring binding of the particle closely to the 
membrane and maybe forming a pore for RNA transfer. On the outside of the virion, VP4’s 
hydrophobic myristic acid contributs to the lipophilicity of the particle and the 
destabilization of its interior. This first intermediate particle sediments at 135 S and is 
therefore called 135S particle or also A (altered) particle. Further conversion leads to RNA 
release. This empty viral shell sediments at 80 S; it is called 80S particle or B particle. 
Since 80S particles are hydrophilic, the externalized N-termini of VP1 must be somehow 
hidden, but not all structural changes can be reversed. An opening at the fivefold axes, a 
10 Å wide channel, can be found in 80S particles and causes an about 4% larger capsid 
compared to the 150S particle. 
2.2.3 Virion structure and properties 
In general, rhinoviruses are typical picornaviruses: they have the non-enveloped 
icosahedral capsid, the genome is a single stranded, positive sensed RNA of about 7100 – 
7300 nt length. It is covalently connected to VPg at the 5’ end and featuring a polyA tail at 
the 3’ end. Translation produces a single 2100-2200 amino acids (AA) large polyprotein 
from one open reading frame (ORF), which is subsequently cleaved into structural and 
non-structural proteins (see Figure 2-5 for a scheme of HRV genome and proteome). The 
5’ UTR is 610-625 nt long, the 3’ UTR 40-47 nt.  
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Figure 2-5. Scheme of the Human Rhinovirus genome. Upper row indicates the length of the 
RNA strand in 1000 nt steps from 5’ on the left to 3’ on the right. Middle row represents the 
RNA with genes indicated. Note the VPg on the 5’ end and the polyA-tail on the 3’ end, both 
followed or presided, respectively, by the UTR. Lower row depicts the large polyprotein and its 
mature cleavage products. Figure from www.uq.edu.au/vdu. 
There is a great variability between the serotypes. Best studied representatives of HRV 
are HRV2, a minor group HRV-A, and HRV14, a major group HRV-B. So far, little is 
known about HRV-C. The HRV icosahedral capsid features star-shaped domes formed by 
VP1 at the fivefold axes. These domes are stabilized from the inside by VP3 and are 
encircled by around 2 nm deep canyons formed by VP1, VP2 and VP3. Beneath the canyon 
floor, within VP1, is a hydrophobic cavity, the pocket, which is filled in some serotypes 
with a fatty acid derived from the host cell, but has been found to be empty in others. The 
fatty acid is believed to stabilize the capsid and has to be expelled prior to uncoating. The 
canyon has been identified as the binding site for the major receptor ICAM-1, the high 
specificity ensures that only humans can be infected with HRV. The binding geometry for 
the minor receptor is totally different and the binding sites are located at the dome.  
The so-called “breathing” is a process of structural changes of the viral capsid [10]. VP4 
is known to be buried inside the capsid around the fivefold axis, only VP1-3 are exposed on 
the external surface. But VP4 is transiently exposed on the viral surface, which can be 
inhibited by antiviral drugs: binding of WIN 52084 to the pocket of the canyon stabilizes 
the HRV14 virion in the closed conformation with VP4 on the inside; infectivity of these 
virions is strongly reduced [10], purportedly because the WIN compound serves like a 
pocket factor for the stabilization of the virion in the closed conformation. 
A characteristic trait of rhinoviruses, which separates them from other enteroviruses 
and has been used for their identification, is their acid lability. Whereas enteroviruses 
retain their infectivity in a pH below 3, which is necessary when passing through the 
stomach to reach the intestinal system, rhinoviruses become inactivated at pH values 
<5.6. When using epithelial cells of the respiratory tract for replication, the pH stability is 
not necessary. The mode of uncoating of viruses mirrors stability or lability at low pH. 
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Acid lability allows for uncoating at the low pH in endosomes, acid stable viruses need 
another trigger for uncoating like receptor attachment.  
Another physico-chemical property is the buoyant density in cesium chloride, which 
reflects the permeability of the capsid. For comparison, the completely tight poliovirus 
capsid reaches 1.34 g/ml, the foot-and-mouth disease virus, whose capsid features pores, 
reaches 1,45 g/ml [5, p. 797]. Rhinoviruses reach an intermediate value with 1.40 g/ml, 
although also lower values have been reported [11]. Internal polyamines limit the amount 
of cesium ions entering the viral capsid, but more ions can enter at long centrifugation 
times in high cesium salt concentrations, contributing to an alteration of the buoyant 
density. 
2.2.4 Viral infection 
Viral replication of HRV takes place in the cytoplasm of the host cell. Therefore, it is 
mandatory for the virus to release its genomic RNA from the viral capsid and transfer it 
across the host cell membrane. Not all virions are able to initiate infection. They can fail to 
complete one of the steps of their life cycle, including attachment, RNA release, genome 
replication and virion assembly. Due to the high error rate of the replicase, also one of the 
numerous incorporated point mutations during replication can be the reason for 
inactivation. The ratio between particles and infectious virus is calculated by counting 
particles (by electron microscopy or spectrophotometrically) and determining the plaque 
forming units (PFU) of a sample. It ranges between 30 and 1000 for picornaviruses [5, p. 
797]. 
Human Rhinoviruses exploit several different cell surface molecules for attachment to 
the host cell, the most important ones being ICAM-1 and LDLR. The binding site of ICAM-
1 is at the base of the canyon, whereas the VLDL receptor footprint in HRV2 is on the star-
shaped dome of the icosahedral fivefold axis formed by the BC and HI loops of VP1 [12]. 
The uncoating process is probably different for major and minor group viruses. While 
ICAM-1 interaction seems to be enough to initiate conformational changes in the capsid 
proteins to allow RNA transfer through the membrane, the LDLR activity is limited to the 
mediation of a clathrin dependent internalization of the virus-receptor complex. The 
receptor causes engulfment of the virion in the cell membrane until a vesicle is formed, 
which proceeds to an early endosome. The endosome matures to a late endosome by 
fusion with other vesicles, associated with a decrease of the pH to a slightly acidic value of 
5.4 – 5.6, depending on the cell type. A conformational change of the receptor and the 
virus due to the low pH releases the RNA from the viral capsid and transfers it across the 
endosomal membrane into the cellular cytoplasm. Elucidating the influence of an acidic 
surrounding on capsid structure, studies in FMDV have shown that the low pH causes 
protonation of histidines along the pentamer interface. Protonated histidine residues 
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repulse each other and therefore the neighboring protomers, causing disassembly of the 
capsid. Affirming the role of histidines in the acid lability of the capsid, mutation of 
histidines causes higher stability of the virion at low pH [13-14]. Similar effects are 
presumed in rhinoviruses which also undergo structural changes upon exposure to a low 
pH. Structural changes of the capsid are necessary to allow for its expansion and the 
opening of 10 Å wide pores for RNA release. It has to be kept in mind that the later on 
presented uncoating processes for major and minor group HRVs are presumed models 
and the exact events of RNA translocation are controversial and have not been visualized 
yet. It is still especially difficult to explain how the RNA can be threaded through a 10 Å 
pore, since it forms complicated secondary structures inside the capsid with mostly double 
stranded regions of at least 20 Å diameter. Either the RNA has to be disentangled into a 
single stranded structure, although it is not known where the energy for unfolding would 
come from, or the pore has to extend, at least temporarily, maybe during the process of 
breathing. 
 Once the RNA has reached the cytoplasm of the cell, it is immediately translated by the 
host cell translational machinery. Viral replication follows the events described for all 
picornaviruses (see section 2.1.3). Once a viral infection is manifested, it induces further 
ICAM-1 receptor expression of surrounding cells, reinforcing viral spreading. 
2.2.5 Major Group Receptor: Human ICAM-1 
The Intercellular adhesion molecule 1 (ICAM-1) (also called CD54) is an integral 
membrane protein and part of the immunoglobuline (Ig) protein superfamily. Its 
physiological ligand is the lymphocyte function-associated antigen 1 (LFA-1), which is 
expressed on the surface of lymphocytes. Hence, ICAM-1 is normally intended to play an 
important role in the host cell’s immune system and is therefore expressed on a wide 
range of cell types, including epithelial cells in the nasopharynx of humans, the hunting 
ground of Human Rhinoviruses. It is also a receptor for some coxsackieviruses. ICAM-1 
consists of 532 AA which are segmented into a 27 AA signal peptide followed by the 
extracellular topological domain, a helical transmembrane domain and an intercellular 
cytoplasmic domain (see Figure 2-6 for ICAM-1 structure). The extracellular domain 
consists of 5 repeats of Ig-like C2-type domains. The actual binding site of ICAM-1 on 
HRVs is the first amino-terminal located Ig-like domain [15-16]; it’s BC, CD, DE and FG 
loops mediate the direct contact of the receptor with the virus. Notably, the virus is kept at 
quite a distance from the membrane via the 5 Ig-like domains. The ICAM-1 protein is 
modified by several glycosylations, phosphorylations and disulfide bonds. 
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Figure 2-6. Schematized structure of ICAM-1, indicating the main areas and domains, from N-
terminus to C-terminus: a signal peptide, the extracellular domain consisting of 5 
immunoglobulin-like domains, a transmembrane domain and the cytoplasmic domain. The 
virus binding site is situated within the first immunoglobulin-like domain. 
The receptor attaches to the viral canyon which encircles the fivefold axis [17]. The 
interacting sequences on the canyon base are contributed by VP1 and VP3 and are highly 
conserved, although they differ in HRV-A and HRV-B. If a pocket factor is present, it is 
pushed out by the receptor to make the buried binding sites accessible and room for 
structural rearrangements. Possibly the virus undergoes the structural changes by itself 
during breathing and the receptor attaches in the right moment and stabilizes the virion in 
the open conformation. Upon binding to the receptor, the major group virus HRV14 
experiences several structural changes. The tight connection between the protomers 
loosens up, allowing an expansion of the viral capsid of about 4%, especially pronounced 
at the domes of the fivefold axes. VP1 forms a channel of about 10 Å diameter at the 
fivefold axes [18], the believed exit point for the RNA. Another important structural 
change of the viral capsid is the loss of VP4 in the process of uncoating. Presumably, it 
inserts into the membrane due to its hydrophobic character and could form a channel 
which would serve as connection between the viral capsid and the cytoplasm. Major group 
viruses probably use the N-terminus of VP1 and the rigid ICAM-1 receptor in addition to 
VP4 to completely disrupt the endosomal membrane concomitantly to RNA release [19]. 
Still, for most serotypes the receptor only mediates the attachment of the virus and is 
just an additional trigger to an acidic pH for RNA release. Tightly bound virus leads to 
internalization of the receptor-virus complex. Although the low pH in late endosomes is 
necessary in addition to the ICAM-1 interaction for RNA release, the contribution of both 
differs in various serotypes, since some are more acid stable than others. The uncoating 
process is also strongly temperature dependant. Only very acid sensitive serotypes can 
infect without ICAM-1 via heparan sulphate, whereas infection via ICAM-1 still works at 
least at a low level in the presence of the H+-ATPase inhibitor bafilomycin.  
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2.2.6 Minor Group Receptor: LDLR family 
LDLR family molecules, including LDLR, VLDLR and LRP, are typical endocytic 
recycling receptors: they are found on the plasma membrane surface but also to a great 
extent in recycling endosomes. Since they possess at least one clathrin-coated pit 
localization signal, they are constitutively internalized via clathrin-dependent endocytosis 
and recycled after ligand detachment. Ligands, either the low-density lipoprotein or HRV, 
dissociate at the mildly acidic pH in early endosomes with the help of a β-propeller 
domain. While the ligand is transported to late endosomes and finally lysosomes, the 
receptor is recycled to the plasma membrane. Members of the LDLR superfamily consist 
of varying repeats of the same domains. The ligand-binding domain contains several, in 
the case of LDLR seven, LDL receptor type A repeats. Each repeat consists of 40 residues 
with three disulphide bonds forming a negatively charged surface which coordinates a 
Ca2+ ion. The second conserved region contains LDL receptor type B repeats consisting of 
EGF-like repeats and YWTD domains (they form the β-propeller). An O-linked 
glycosylation domain is present in LDLR and VLDLR, but not LRP. The receptor is 
membrane-bound via a transmembrane domain, followed by the cyptoplasmic tail 
containing one or two consensus sequences Asn-Pro-Xaa-Tyr (NPxY) for receptor 
internalization signaling via phospho-tyrosine binding (PTB) domains. The β-propeller is 
the reason for the acid-dependent structural changes of the receptor which results in 
ligand dissociation. Figure 2-7 depicts the LDLR in open and closed conformation, 
depending on the pH. 
 
Figure 2-7. The low density lipoprotein receptor at a mildly basic pH on the cell surface 
(left) and at an acidic pH in the endosome (right). Note the structural change at low pH, a 
turning of the β-propeller causes the extended ligand-binding domains to fold back to a closed 
structure and thereby release the bound ligand. Figure from [20] 
 
The LDLR family is used as receptor by 12 members of the HRV-A species. There are 
several important differences between attachment of HRV to LDLR and to ICAM-1. Upon 
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binding to the LDL receptor the virus does not automatically undergo structural changes 
like it is the case with the major group receptor ICAM-1. Also the attachment geometry of 
the virus is different: LDLR does not bind to the canyon encircling the fivefold axis, but to 
the dome on the fivefold axis itself [21]. Therefore it is not able to stabilize the virion in the 
open conformation and it is strictly dependent on the low pH (≤ 5.6) in late endosomes for 
RNA release and transfer. This was shown with an inhibitor of the V-ATPase which blocks 
the pH decrease in endosomes [22-23]. The result was strong inhibition of infection.  
Upon exposure to low pH, also minor group viruses exhibit an expanded capsid and 
pore formation at the fivefold axes. The empty capsids have lost all VP4, in contrast to 
major group capsids. Also, they have an extended β-cylinder at all 12 fivefold axes. Minor 
group virions probably stay inside the endosome and only transfer their RNA through the 
channel into the cytoplasm. In contrast to the ICAM-1 mediated infection pathway, the 
subviral particles can be found in late endosomes and lysosomes, whereas the RNA 
escapes the lysosomal degradation, indicating that the RNA has been released within the 
endosome and was transferred via an ion-conducting pore to the cytoplasm, leaving the 
empty capsid behind. 
The minor group receptor is either LDLR or LRP. For VLDLR a very high binding 
affinity has been demonstrated, but due to its tissue distribution (it is mainly found in 
skeletal muscle, heart and organs except liver) it is unlikely to be used as HRV receptor in 
vivo. Nevertheless its high affinity has been utilized for recombinantly produced receptor 
models. The highest binding affinity was achieved by cloning a concatemere of five 
domains 3 of the VLDLR. By linking them to a maltose binding protein (MBP) and a His6-
tag [24-25], the soluble MBP-V33333-His6 receptor can be attached to the Nickel 
complexing lipid DOGS-NTA incorporated in liposomes. This provides an artificial model 
system for the complex and difficult to study in vivo cellular situation. 
2.3 Nanocontainers 
To study viral infection, in particular the poorly understood process of RNA release 
from the virion and transfer across the endosomal membrane, the complex system of cells 
is a major problem. So far, no structure of uncoating intermediates on cellular membranes 
could be resolved. High magnifying microscopy like cryo-electron microscopy of cellular 
compartments is difficult, therefore high resolution pictures of the bound virus during the 
uncoating process have not yet been taken. Also elucidation of viral infection and the 
inhibitory effect of different molecules on it is a tricky process in cell culture. Cells are 
complex systems and modifying just one specific parameter without causing unintended 
additional changes is merely impossible. Liposomes have been established as a simple and 
easy to modify model of a cell or cellular compartment. They can be employed for tackling 
different questions, only using the minimal requirements to make the process work. That 
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way these requirements can not only be identified, but also manipulated with drugs or 
high concentrations of a compound which would kill cells and stop any further study. The 
lipid composition of biological membranes is crucial for their functional properties, 
therefore to make results obtained with this model as relevant for the in vivo situation as 
possible, it is mandatory to mimick the host cell membrane as closely as possible. The 
uncoating of HRV occurs at the endosomal membrane, hence that one has to be employed 
for RNA transfer studies like they were done in the course of the present thesis. 
2.3.1 Endosomal Membranes 
Endosomes are transport vesicles inside eukaryotic cells. Their function is to collect 
cargo from the plasma membrane, e.g. free or loaded receptor, and navigate it through the 
cell, as well as the other way around, to release membrane-bound or soluble molecules on 
the plasma membrane of the cell. Depending on the cargo’s destiny, it has to be sorted into 
different cell compartments. The plasma membrane derived vesicles fuse with early 
endosomes which have an only mildly acidic pH. Upon maturation into late endosomes 
the pH decreases via the action of V-ATPases. Molecules intended for recycling are 
concentrated in tubules which bud off the early endosomes and transport their cargo back 
to the plasma membrane as recycling endosomes. Late endosomes fuse with lysosomes, 
forming the lysosomal endosomes, which feature high density, an acidic pH and degrading 
enzymes. 
The membrane of early endosomes is similar to the plasma membrane, but on maturation 
to late endosomes there are some dramatic shifts of lipid composition. According to two-
dimensional chromatography and autoradiography of 32Pi-labeled phospholipids of 
purified late endosomes, the membrane consists besides 1/3 of cholesterol of around 32 % 
PC, 13% PE, 3% PI, 1% PS, 6% SM and 11% LBPA [26-27].  Figure 2-8 depicts the mean of 
the concentrations given in the references. Phosphatidylcholine (PC) self-organizes 
spontaneously as a typical planar bilayer in which each lipid molecule has a nearly 
cylindrical molecular geometry, with the lipophilic tails facing each other and the polar 
headgroups facing the aqueous phase. They also account for the membrane fluidity at 
room temperature [27]. In contrast to PC, Phosphatidylethanolamine (PE) has a conical 
molecular geometry because of the relatively small size of its polar headgroup, hence 
exerting influence on the membrane shape. Also it has been found that the various lipids 
are asymmetrically distributed between the two bilayer leaflets, adding another factor that 
contributes to curvature stress in biomembranes. Phosphatidylserine (PS) is mainly a part 
of the inner plasma membrane leaflet and is found in traces in the cytosolic leaflet of 
endosomes and lysosomes. Several signalling and fusogenic effector proteins with specific 
phosphatidylserine-binding domains can direct vesicle fate via PS. Phosphatidylinositol 
(PI) is also important in the physiological system as a signaling lipid which is necessary for 
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defining the organelle identity and recruiting of proteins. Sphingomyelin (SM) consists of 
ceramide as a hydrophobic backbone plus oligosaccharides. Due to their saturated fatty 
acid tail they are able to form tightly packed solid phases which have to be fluidized by 
other lipids like sterols. Cholesterol (Ch) is the main non-phosphorylated lipid in 
mammals. It belongs to a family of polycyclic compounds known as sterols which are not 
only important for membranes but for lipid metabolism in general as they are also part of 
vitamins, hormones and bile acids, amongst others [28]. 
2.3.2 Liposomal membrane 
For the in vitro production of liposomes the lipids were chosen in a way to closely 
resemble the lipid composition of physiological late endosomes and at the same time 
incorporate functional lipids for subsequent experiments, like proposed by Gerhard Bilek 
[29]. The small portion of functional lipids of the mammalian cellular late endosomes like 
PI and PS were omitted, since their signaling activity for messenger proteins is of no 
interest in a pure liposome sample used for viral infection experiments. Instead, up to 10 
mol% of dioleoylglycerol-succinyl-nitriloacetic acid (nickel salt) (Ni-DOGS-NTA) were 
incorporated as attachment site for His6-tagged proteins and, if required, 1 mol% of 
nitrobenzoxadiazol phosphocholine (NBD-PC), a fluorescence labeled lipid, were applied 
for liposome tracing. The used 30 mol% cholesterol were comparably to the in vivo 
situation, the second-frequent lipid PC was represented by a share of 20 mol% 
palmitoyloleoylglycero phosphocholine (POPC). The rest was made up by 20 mol% PE and 
20 mol% SM. A comparison of membrane compositions of late endosomes according to 
the literature [26-27]   and of the liposomes produced here is presented in Figure 2-8. 
 
Figure 2-8. Comparison of the lipid compositions of physiological late endosomes according to 
van Meer and Kobayashi [26-27] and here presented nanocontainers. 
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2.3.3 Proof of RNA transfer 
It is difficult to prove RNA transfer into liposomes. Normally, RNA is detected by 
reverse transcription (RT) and subsequent polymerase chain reaction (PCR) or 
quantitative PCR (qPCR). For these methods, the liposomes carrying RNA in their lumen 
have to be separated from viral particles and from not correctly transferred RNA on the 
outside. This is tricky and the result can be flawed by loss of correctly transferred RNA or 
by accidentally detecting outside RNA. Direct detection of the RNA inside the liposomes is 
by far preferable. A method had been developed by Bilek [29], where liposomes of the 
above presented composition were prepared and filled with all classical components for 
reverse transcription except the template, i.e. enzyme-specific buffer, dNTPs, reverse 
primer, DTT, reverse transcriptase and an RNase inhibitor; these liposomes are  as from 
now on called “nanocontainers”. They were decorated on the outside with the recombinant 
soluble minor group receptor MBP-V33333-His6 [25, 30]. HRV2 was allowed to attach to 
the receptor and was then triggered to release its RNA and transfer it into the 
nanocontainers where it was transcribed into cDNA by the RT kit. The liposomes were 
permeabilized with a detergent and the cDNA amplified via PCR to give a visible signal on 
an agarose gel.  
When putting the theory into practice the model system appeared to be unreliable, 
often giving no signal, whereupon it was not known if the system failed in transferring the 
RNA or in subsequently detecting it. 
 
2.4 Aim of the project 
The present diploma thesis focuses on solving the above described problem of 
unreliability of the newly developed model system for viral RNA transfer through lipid 
membranes. HRV2 RNA should be detected reliably upon transfer into liposomes 
decorated with a recombinant VLDLR and filled with a reverse transcription kit, called 
nanocontainers. Furthermore, the model system should be refined, characterized and 
extended to major group HRVs by cloning a soluble ICAM-1 receptor. 
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3 Materials and methods 
 
Buffers 
abbreviation name ingredients 
TrisNaCl 50 mM Tris, 80 mM NaCl, pH 
8.3 
3 g Tris (AppliChem) 
2.5 g NaCl 
conc. HCl ad pH 8.3 
dH2O ad 500 ml 
NaAc 1 M NaAc pH 5.0 136 g sodium acetate 
glacial acetic acid ad pH 5.0 
dH2O ad 1000 ml 
TBS 10 x TBS 
250 mM Tris pH 7.5, 1.5 M NaCl 
250 ml 121 g Tris (AppliChem) 
 conc. HCl ad pH 7.5 
 dH2O ad 1000 ml 
300 ml 146 g NaCl 
 dH2O ad 500 ml 
450 ml dH2O 
CaCl2 1 M CaCl2 147 g CaCl2 
dH2O ad 1000 ml 
TBSC 25 mM Tris, 150 mM NaCl, 10 
mM CaCl2 
100 ml 10x TBS 
10 ml 1 M CaCl2 
dH2O ad 1000 ml 
TAE 50 x TAE 242 g Tris (AppliChem) 
57.1 ml glacial acetic acid 
37.2 g Na2EDTA.2H2O 
dH2O ad 1000 ml 
Running buffer 10 x SDS-PAGE running buffer 144 g glycine (AppliChem) 
30 g Tris (AppliChem) 
10 g SDS (BioRad) 
dH2O ad 1000 ml 
NaOH 1 M NaOH 40 g NaOH 
dH2O ad 1000 ml 
borate buffer 50 mM boric acid, pH 8.3 3.1 g boric acid (Sigma-Aldrich) 
3 M NaOH to pH 8.3 
dH2O to 1000 ml 
Chemicals were purchased from Merck, Darmstadt, Germany if not indicated otherwise. 
Other suppliers: Bio-Rad Laboratories, Hercules, CA, USA; Sigma-Aldrich, St. Louis, MO, 
USA; AppliChem, Darmstadt, Germany. 
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Lipids 
name abbreviation Avanti Polar Lipids 
catalog# 
1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine 
POPC 850457P 
L-α-phosphatidylethanolamine PE 841118P 
sphingomyelin SM 860062P 
1,2-dioleoyl-sn-glycero-3-[(N-(5-
amino-1-carboxypentyl)iminodiacetic 
acid)succinyl] (nickel salt) 
Ni-DGS-NTA 790404P 
cholesterol from ovine wool Ch 700000P 
1-Oleoyl-2-[12-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]lauroyl]-
sn-Glycero-3-Phosphocholine 
NBD-PC 810133P 
All lipids were purchased from Avanti Polar Lipids, Inc., Alabaster, Alabama, USA 
(http://www.avantilipids.com) via Instruchemie, Delfzijl, Netherlands.  
 
3.1 Liposome Preparation 
Preparation of multi-lamellar vesicles (MLV):  
Lyophilized lipids (Avanti Polar Lipids via Instruchemie, Delfzijl, Netherlands) were 
dissolved in chloroform p.A. to 10 mM stocks of POPC, PE, SM and cholesterol. Ni-DGS-
NTA and NBD-PC stocks were 10 mg/ml which corresponds to 9.3 and 11.3 mM, 
respectively. Stocks were stored in glass vials with teflon lined caps, covered with N2, at -
20°C. A lipid membrane was prepared, consisting of POPC : PE : SM : Ch : Ni-DGS-NTA 
and NBD-PC, the latter only if the liposomes were intended for fluorescence detection 
uopn flotation. A total of 5 µmol dissolved lipids in the ratio 1 : 1 : 1 : 1.5 : 0.5 (: 0.05) were 
mixed in a 25 ml pointed bottom glass flask, that corresponded to 100 µl POPC, 100 µl PE, 
100 µl SM, 150 µl cholesterol, 54 µl Ni-DGS-NTA and 4.5 µl of the NBD-PC stock if 
necessary. The flask was rotated (55 rpm) under a constant stream of nitrogen gas on a 
Büchi Rotavapor for at least 3 hours to evaporate all traces of solvent and dry the lipid film 
on the glass wall. It was then hydrated for 2 hours under further constant rotation (45 
rpm) with a reverse transcription kit composed of 30 µl 10 µM reverse primer 
(GAAACACGGACACCCAAAGTA, according to Lu et al. [31] (1 µM end concentration), 15 
µl 10 mM dNTP mix (Promega), 60 µl 5x RT first strand buffer (Invitrogen), 15 µl 
Recombinant RNasin Ribonuclease Inhibitor (Promega), 15 µl SuperScript III Reverse 
Transcriptase (Invitrogen) and 165 µl nuclease free water (Qiagen) to a total volume of 
300 µl. No dithiothreitol (DTT) was added. Three short intervalls of vortexing during the 
last 30 min of hydration helped detaching the lipid film from the wall. The resulting 17 
mM lipid suspension consisted of MLV (multi-lamellar vesicles) and was stored at 4°C 
until extrusion. 
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Extrusion of MLV to LUV:  
To form LUVs (large unilamellar vesicles) of uniform size, a Mini-Extruder (Avanti 
Polar Lipids) was employed at room temperature.  
 
Figure 3-1. Parts of the Mini Extruder (Avanti Polar Lipids) in the order of their assembly. 
Multilamellar vesicles are applied to the extruder with a syringe inserted either in the left or 
right Internal Membrane Support and pushed through the extruder into a second empty 
syringe on the other side. Taken from Avanti Polar Lipids, Inc., http://www.avantilipids.com 
 
Assembly of the extruder (depicted in Figure 3-1) started with washing all parts with 
water to remove dust and soaking four pieces of Filter Supports (Avanti Polar Lipids, 
catalog# 610014, purchased via Instruchemie, Delfzijl, Netherlands) in dH2O. After fitting 
the black rubber rings (O-rings) into the cylindrical Internal Membrane Supports, two wet 
Filter Supports were placed in the middle of each ring. One support complex was slid into 
the metallic Extruder Outer Casing and covered with two polycarbonate membranes 
(Nucleopore Track-Etch Membrane, 19 mm, 0.4 µm pore size, Whatman, catalog# 
800282) with a pore size of 400 nm. The second support complex was inserted, extended 
with the white teflon Bearing ring and the extruder was closed with the metallic Retainer 
Nut, not using a wrench.  The void of the extruder was wetted and filled with 50 mM Tris 
80 mM NaCl 3 mM MgCl2 buffer. The MLV suspension was applied to the extruder with a 
flat-needle Hamilton syringe and passed through the polycarbonate membrane pores 41 
times into a second syringe at room temperature. If liposomes of smaller size were 
desired, it would have been possible to continue the extrusion with a polycarbonate 
membrane of a pore size of 0.2 µm. LUVs were either directly used in experiments or 
stored at 4°C. After total disassembly of all extruder parts and also syringes, every part 
was washed first with water and then ethanol. 
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Purification by mini-size-exclusion-chromatography (mSEC):  
Sephadex G-50 (medium) (Amersham Biosciences) was swollen in 50 mM Tris 80 mM 
NaCl (short: Tris NaCl) buffer over night at 4°C and used to pack a Spin-X Centrifuge 
Tube Filter equipped with a 0.45 µm pore size cellulose acetate membrane (Corning, 
purchased via Szabo-Scandic). 900 µl swollen Sephadex were used in two steps for each 
column, excess buffer was removed by centrifugation (see Figure 3-2 for a scheme of the 
mSEC procedure).  
 
 
Figure 3-2. Mini Size Exclusion Chromatography. First two steps serve the Sephadex G-50 
column formation, two columns have to be prepared for each sample. Then the nanocontainer 
sample is applied on top of the first column and centrifuged through. After a step of washing, 
the flow-through is applied to the second column and purified in the same way.  
 
First the column was filled with 450 µl Sephadex and centrifuged for 30 seconds at 800 
rpm in an Eppendorf 5424 tabletop centrifuge, then it was filled with another 450 µl 
Sephadex and centrifuged for 1 min at 2000 rpm and 1 min at 3000 rpm. 10 µl of LUV 
suspension, which had shortly been reloaded with 1.3 mM final concentration NiCl2, were 
applied to the column and sieved by centrifugation at 3000 rpm for one minute. 5 µl 
buffer were used in the same way for rinsing. The filtrate was subjected to a second round 
of purification on a fresh column which produced 1:4 diluted but well purified liposomes. 
 
Nanocontainer system: 
The standard procedure of performing RT-PCR with the nanocontainer system is 
depicted in Figure 3-3.   
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Figure 3-3. Standard RT-PCR reaction employing the nanocontainer system. 15 µl LUVs 
purified by mSEC were decorated with receptor and then virus, each for 30 min at room 
temperature. Typical amounts for one sample were 64 nmol lipid, 36 pmol receptor and 
around 90 fmol HRV2 in TrisNaCl buffer in a total volume of 19.4 µl. Decorated liposomes 
were exposed to a low pH of 5.4 for 15 min by addition of 1.2 µl 1 M NaAc buffer pH 5.0, 
followed by reneutralization with 0.6 µl 1 M NaOH to a pH of 8.3 and 1 hour at 37°C to perform 
the reverse transcription. After the enzyme was inactivated at 70°C for 15 min, the liposomes 
were disrupted with 1 µl of 20% Triton X-100 and 2.5 µl of the sample were used as template in 
a 50 µl PCR reaction. The amplified product was applied to an agarose gel. 
Controls and application of the system for different purposes made it necessary to 
customize the procedure accordingly, by omitting or adding one or several steps of the 
standard protocol or changing the concentrations. The PCR product was made visible on 
an agarose gel. Individual steps are described below. 
 
Decoration:  
15 µl of mSEC purified LUVs (corresponding to 64 nmol lipid) were mixed at ambient 
temperature with 1 µl (corresponding to 36 pmol) recombinant V33333 receptor or 
dilutions of that if indicated and incubated for 30 min. The same incubation time was 
applied after addition of virus, concentrated or diluted in Tris NaCl buffer (amount is 
indicated for each experiment, it differed from around 1 to 1000 fmol) in a total sample 
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volume of 19.4 µl. After decoration of the liposomes with receptor and virus, the RNA 
release of the virus was triggered by pH adjustment to 5.4 for 15 min with 1.2 µl 1 M NaAc 
pH 5.0. Reneutralization to a pH of 8.3  was achieved with 0.6 µl 1 M NaOH. 
 
Calculation virus : liposome ratio: 
The calculations were performed in Microsoft Excel. Starting point was the material 
liposomes are made of: 5 different lipids, each with a certain size (POPC [32], PE [33], SM 
[34], Chol [35], DGS-NTA [36]). Weighed according to their share of total lipid, the mean 
surface for one lipid molecule was 0.54 nm2. The surface of a 400 nm diameter sphere 
consisting of a double layer was calculated to be 980491 nm2 with the formula 4 x π x r2 x 
2. Dividing the spherical surface by the mean lipid surface resulted in the number of lipid 
molecules incorporated in one liposome. The total amount of lipid used for liposome 
preparation was known to be 0.017 M, multiplication with 6,022 x 1023 (Avogadro 
constant) gave the number of lipid molecules per liter preparation. By dividing the 
number of lipid molecules/liter by the number of lipid molecules/liposome, the amount of 
liposomes/liter preparation could be estimated. Via division by the Avogadro constant this 
amount can also be expressed as mol liposome/liter preparation. One RT-PCR sample 
contained 3.75 µl concentrated liposomes, which corresponded to 3.5 x 10-14 mol. 
Virus input was calculated from 7.3 mg/ml virus. HRV2 has a relative molecular mass 
of 8 MDa, therefore the virus stock contained, according to the formula n = m/M, 9.1 x 
10-13 mol virus/µl. Thus 1 µl of a 1:10 dilution of virus, a typical amount for one sample, 
would correspond to 9.1 x 10-14 mol virus in the RT-PCR sample. Dividing the calculated 
mol virus by the mol liposomes present in one sample gave the desired mol virus/mol 
liposome. 
The amount of employed virus could also be expressed as TCID50. Applying the same 
TCID50 : total liposomal surface ratio to the surface of an average cell, the corresponding 
TCID50 : cell ratio was deduced and compared to usually employed values of MOI in cell 
culture.  
 
Reverse transcription:  
As a control of reverse transcription, 20 µl positive control samples consisting of: 10 µl 
H20, 2 µl 1 µM reverse primer, 1 µl 10 mM dNTP mix, 4 µl 5x first strand buffer, 1 µl 
RNasin (Promega), 1 µl diluted HRV as template and 1 µl SuperScript III reverse 
transcriptase (Invitrogen) were prepared. HRV dilution was varied between 1:10 and 
1:1000 (corresponding to 91 fmol to 0.9 amol) and RNA release was triggered comparably 
to the samples containing nanocontainers with a pH of 5.4 for 15 min. This control also 
acted as a size standard for the desired PCR product. The reverse transcription reaction 
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was performed with all samples for 1 h at 37°C, followed by 15 min at 70°C to inactivate 
the enzyme.  
 
PCR:  
Each 50 µl PCR reaction contained 40 µl H2O, 5 µl 10x pfu buffer, 1 µl 10 mM dNTP 
mix (Promega), 0.5 µl 10 µM primer forward (CPXGCCZGCGTGGC according to Lu et al. 
[31], obtained from Exiqon, Vedbaek, Denmark; also see primer list in attachment), 0.5 µl 
10 µM primer reverse, 2.5 µl cDNA template and 0.5 µl pfu DNA polymerase (Promega). 
After an initial step of 2 min at 95°C for enzyme activation, the amplification was 
performed during 60 cycles of 45 s 95°C for denaturation, 45 s 60°C for primer annealing 
and 2 min at 72°C for elongation, followed by 10 min at 72°C for final elongation in an 
Eppendorf Masterycler gradient. 
 
Agarose gel:  
1% agarose gels were prepared with 0.4 g standard electrophoresis agarose (genXpress) 
and 40 ml 0.5x TAE buffer. If intended for RNA instead of DNA the buffer was prepared 
with DEPC treated water. GeneRuler 1 kb DNA ladder (Fermentas) was used as a size 
standard, the samples were loaded with 6x DNA loading buffer (Fermentas) or RNA 
loading buffer and the gel was usually run at 80 V for 20 min. It was then incubated for 15 
min in an ethidium bromide bath before taking a photograph under UV illumination in a 
GelDoc-It TS Imaging System (UVP). 
 
ImageJ: 
Signal intensity of agarose gel bands was quantified with ImageJ 
(http://rsbweb.nih.gov/ij/), a program which integrates intensity and area of a gel band 
into numbers, according to an online user manual 
(http://panic.berkeley.edu/~ghe/GelDoc/UsingImageJ/). In short: A grayscale 
photograph of the gel is necessary for this purpose. First the area around the bands was 
selected with the Rectangular selection tool and appointed by Ctrl + 1. The rectangle was 
dragged to an appropriate area above, which only contained background and appointed by 
Ctrl + 2. By pressing Ctrl + 3, the program gives a grayscale profile of both the lanes and 
the background. Peaks had to be separated by hand via drawing vertical lines between 
them with the Straight line selection tool (pressing Shift at the same time makes sure the 
line is really vertical). The area of each peak plus associated background peak was 
annotated with the Wand tool, the program automatically gave the results after 
Analyze/Gels/LabelPeaks had been opened. The results, which included the area of each 
peak and its percentage of the total area, were copied into an Excel file. There the 
RNA transfer of HRV through model membranes 
Materials and methods 
- 30 -  diploma thesis by Nena M. Matscheko 
 
background area was subtracted from the band area to give the final signal intensity, 
which was then plotted in a bar chart. 
 
Transmission Electron Microscopy:  
Microscopy was performed by Angela Pickl-Herk. Carbon-coated copper grids were 
taken from the vacuum storage box and glow discharged for 30 s at 20 mA. They were 
loaded with 4 µl sample, incubated for 1 min and drained with filter paper. The samples 
were stained by incubation with 4 µl 2% Na-phosphotungstate (PTA) pH 7.3 twice for 1 
min. The loaded grids were stored in vacuum until pictures were taken at 80 kV with the 
FEI Morgagni transmission electron microscope (FEI, Hillsboro, Oregon, USA) using an 
11 Mpixel CCD camera. 
 
qPCR virus dilution series:  
HRV2 was serially diluted, RNA release was triggered by exposure to 56°C for 10 min 
and the sample was subjected to reverse transcription in a 19.4 µl total volume RT mix. In 
addition, 1 µl of concentrated virus was added to an RT mix, triggered to release its RNA, 
reverse transcribed and diluted to give the same dilution series. Five µl of the solution 
containing the cDNA template were mixed at ambient temperature with 12.5 µl 2x Taq 
polymerase Red Mix (Ampliqon), 0.1 µl 100 µM primer forward, 0.1 µl 100 µM primer 
reverse, 0.25 µl 1 µM Fluorescein additive (Eurogentec), 1 µl 25x SYBR Gold and 6.05 µl 
H2O to a total volume of 25 µl. Negative controls with dH2O instead of cDNA template 
were included in every run. Samples were run on a Bio-Rad iCycler with iQ5 optical unit or 
an Eppendorf realplex Mastercycler with following parameters: 2 min 95°C to initiate the 
enzyme, 45 cycles of 15 sec 95°C for denaturation, 15 sec 60°C for primer annealing and 1 
min at 72°C for elongation and fluorescence measurement, followed by the production of a 
melting curve between 50° and 95°C. Threshold cycles and corresponding virus dilutions 
were applied for the calculation of a standard curve using Microsoft Excel.  
 
RNA in vitro transcription:  
pBluescriptHRV2, a T7 promoter containing vector which carries the cDNA of HRV2, 
was used as template in a PCR with forward primer HRV2_3end 6849 and reverse primer 
HRV2_5end 561-583 (see primer list in section 8.2). The same PCR mix was used as 
described before, except for only 0.3 µl pfu DNA polymerase. The protocol started with 2 
min 95°C, 35 cycles of 45 s 95°C, 45 s 50°C and 9 min 72°C, followed by 10 min 72°C. To 
control the product, 5 µl were applied to an agarose gel. The DNA was ethanol precipitated 
by filling up the finished PCR reaction to 100 µl with dH2O, 1 ml 96% ethanol and 50 µl 3 
M NaAc pH 5.2, incubating for 30 min at -80°C, pelleting the DNA at 13000 rpm in an 
Eppendorf tabletop centrifuge, 4°C, for 20 min, washing the pellet with 750 µl 70% 
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ethanol and resuspending it in 15 µl dH2O. For in vitro transcription, using the 
MEGAscript Kit (Ambion), 0.3 µl of that template were used. It was adhered to the given 
protocol, allowing transcription for 4 hours. The produced RNA was extracted by Phenol-
Chloroform-Extraction (see in section 3.2) and resuspended in 50 µl H2O (Ambion). The 
RNA concentration was measured with a NanoDrop (peqlab) and the quality of the 
product was checked on a DEPC agarose gel. 
 
Capillary Electrophoresis:  
This was realized in cooperation with Xavier Subirats on a capillary electrophoresis 
machine (Hewlett-Packard 3D CE). For determination of the EOF, DMSO was used in a 
1:200 dilution as neutral marker that would run in front of the virus and benzoic acid as a 
second internal standard that would run behind the virus. 1 µl virus sample was mixed 
with 0.7 µl 1:200 diluted DMSO, 0.9 µl benzoic acid and 12.4 µl 100 mM borate buffer pH 
8.3 (sample buffer) to a total sample volume of 15 µl. A blank had the same composition 
except for replacing the virus with buffer. Vials with 1 M NaOH, H2O and an empty one 
were prepared and placed into the CE vial chamber. NaOH was set as Inlet and waste as 
Outlet and the capillary was flushed for 5 min. Then the Inlet was changed to H2O and it 
was flushed for another 5 min. The background electrolyte (BGE) was prepared by adding 
10 mM Thesit to the sample buffer, 3 vials were filled with exactly the same volume (350 
µl) of BGE. The capillary was flushed with BGE at the end of the washing procedure. After 
setting the Inlet to the sample vial, the run was started and the time and absorbance at 
200 and 260 nm were measured. Since the migration time usually changes from run to 
run to some extent, the electrophoretic mobility of the peaks was determined from the 
total length of the capillary (Ltot), length of capillary from sample uptake until detector 
(Leff), time of peak appearance of DMSO (tDMSO) and time of peak appearance of analyte 
(tA). Effective mobility of the analyte (μeff) is the value of μobs minus μEOF, which can be 
calculated by the following equations: 
 (1) μobs = 1/tA*Leff*Ltot/V          
 (2) μEOF = 1/tDMSO*Leff*Ltot/V 
 (3) μeff = μobs - μEOF 
 
Flotation in a sucrose step gradient:  
For the sucrose step gradient, fresh sucrose solutions of 67% and 25% w/v (6.7 and 2.5 
g sucrose, respectively, were brought to 10 ml with Tris NaCl buffer) were prepared, 
dissolving was accelerated by heating to 80°C in a water bath. Liposomes with 
incorporated NBD were prepared with receptor and virus at different molar ratios like 
described for liposomes for RT-PCR (above) and diluted with Tris NaCl buffer to a total 
volume of 50 µl. Each sample was mixed with 150 µl 67% sucrose solution to give 200 µl 
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50% sucrose solution, which was transferred to the bottom of an 11x34mm centrifuge tube 
(Beckman). It was overlaid with 900 µl 25% sucrose solution slowly drop by drop on the 
wall of the tube and with 900 µl Tris NaCl buffer as 0% sucrose solution. The tubes were 
evenly balanced and placed in a TLS55 swing out rotor. Centrifugation was performed on 
an Optima TLX Ultracentrifuge (Beckman) for 4 hours at 4°C, 45000 rpm. Aliquots of 167 
µl were taken from the top and transferred to a 96 well plate. Fluorescence of NBD-PC in 
each aliquot was determined by a Wallac Victor2 plate reader (PerkinElmer) and 
corresponded to the amount of liposomes. The fraction with the highest liposome 
concentration was chosen for TEM imaging. A TCID50 assay was performed with a 2 µl 
aliquot of each fraction of a sample with receptor and a control sample without receptor. 
Aliquots containing most of the liposomes were combined and exposed to a pH of 5.4 for 
15 min by the addition of 1 M NaAc pH 5.0 to trigger the RNA release (660 µl flotated 
liposomes + 39.6 µl 1 M NaAc). After reneutralization to a pH of 8.3 with 1 M NaOH (19.6 
µl), reverse transcription was performed at 37°C for one hour, then the enzyme was 
inactivated by heating to 70°C for 15 min. Produced cDNA was precipitated after 
disintegration of the liposomes with 1% TritonX by addition of 1/10 volume 3 M NaAc, 2 µl 
20 mg/ml glycogen and 2.5 times the volume 96% ethanol and incubation at -80°C for 30 
min. Precipitate was pelleted by centrifugation at 14000 rpm for 15 min at 4°C in an 
Eppendorf tabletop centrifuge, washed with 700 µl 70% ethanol and another 5 min 
centrifugation and then left to dry for some minutes at room temperature. The pellet was 
dissolved in 20 µl H2O and subjected to PCR. 1/4 of the PCR reaction was applied to a 1% 
agarose gel and the DNA was stained with ethidium bromide. A positive control consisting 
of the RT mix alone was included in RT, precipitation and PCR. 
 
Median tissue culture infective dose (TCID50) assay: 
TCID50 assays were performed by Irene Goesler. Hela cells in 100 µl infection medium 
(MEM + 2% FCS, 1% pen/strep, 1% glutamine, 30 mM MgCl2) were seeded in 96 well 
plates and grown overnight at 37°C. Samples containing virus were serially diluted in 
infection medium to give 10 fold dilutions. A sample from each dilution was spread on the 
cells of 12 wells and incubated at 34°C for 5 days. The wells were stained with 80 µl 0,1% 
crystal violet in H2O per well for 10 min and cell free wells were counted. 
 
 
 
3.2 Cloning of soluble ICAM-1 receptor 
Stock of pCDM8ICAM1:  
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The plasmid carrying the ICAM-1 encoding gene was obtained from Addgene 
(plasmid# 8632) in the bacterial host strain MC1061/P3. Bacteria were spread on an agar 
plate containing 12.5 µg/ml ampicillin and 16 µg/ml tetracycline and incubated overnight 
at 37°C. A single colony was used for inoculation of 100 ml LB+Amp+Tet, which were 
again incubated at 37°C overnight. 500 µl of culture were mixed with 500 µl 87% glycerol 
and frozen in liquid nitrogen for storage at -80°C. The rest of the culture was used for a 
Midi prep to gain a stock of purified pCDM8-ICAM1 plasmids at a NanoDrop determined 
concentration of 4.6 µg/µl. This plasmid DNA was the starting material for both cloning 
strategies. 
 
Mini prep employing the Invisorb Spin Plasmid Mini Kit (Invitek):  
A single colony was picked with a sterile pipette tip and transferred to a test tube 
containing 2 ml LB+antibiotic. Incubation overnight at 37°C and constant shaking allowed 
bacterial replication. Suspension was transferred to a 2 ml tube and centrifuged for 1 min 
at 14000 rpm on an Eppendorf tabletop centrifuge. Supernatant was discarded and pellet 
resuspended in 200 µl Resuspension Solution of the Invisorb Spin Plasmid Mini Kit 
(Invitek). 200 µl Alkaline Lysis Solution were applied and lysis was performed for up to 5 
min. After the addition of 200 µl Neutralization Solution it was mixed by shaking the tube 
and then centrifuged at 14000 rpm for 5 min. The supernatant was decanted into the 
prepared Spin Filter which had been placed into a 2 ml Receiver Tube and 200 µl Binding 
Solution were added. The tube was inverted to mix the solutions and centrifuged for 1 min 
at 8000 rpm in an Eppendorf tabletop centrifuge. After discarding the filtrate 750 µl Wash 
Buffer PL were centrifuged through in the same way.  The emptied tube was subjected to 3 
min of centrifugation at 14000 rpm for drying and the filter was moved to a 1.5 ml 
Receiver Tube and 60 µl Elution Buffer P were applied and allowed to soak for 10 min. To 
elute the plasmid DNA, centrifugation was performed for 1 min at 8000 rpm. 
 
Midi prep employing the NucleoBond Midi Kit (Macherey-Nagel):  
100 ml LB+antibiotic were inoculated with bacterial suspension derived from a single 
colony and incubated on a shaker at 37°C overnight. Bacteria were pelleted by 
centrifugation at 4°C, 4200 rpm for 15 min in a Megafuge 1.0R (Heraeus Instruments) 
centrifuge.  The NucleoBond Midi Kit (Macherey-Nagel) was used to extract the plasmid. 
The pellet was resuspended in 4 ml buffer S1+Rnase A. After addition of 4 ml buffer S2 the 
tube was inverted 8 times and incubated at ambient temperature for up to 5 min. 4 ml pre-
chilled buffer S3 were added, the tube again inverted 8 times and then cooled on ice for 5 
min. While centrifuging at 12000 rpm at 4°C for 25 min in a Sorvall RC5C centrifuge 
(Sorvall SS34 rotor), the provided AX100 columns were equilibrated with 2.5 ml buffer 
N2. The supernatant was applied to the column. Once the sample had passed the filter the 
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column was washed with 10 ml buffer N3. Elution was done with 5 ml buffer N5, directly 
into a tube containing 3.5 ml isopropanol. DNA was pelleted by centrifugation at 14000 
rpm at 4°C for 30 min in an Eppendorf 5415C tabletop centrifuge, followed by a washing 
step with 3 ml 70% ethanol and again centrifugation at 14000 rpm, now at ambient 
temperature for 15 min. The supernatant was aspirated off, the pellet left to dry at room 
temperature for 10 min and then resuspended in 100 µl pure H2O (Qiagen). The DNA 
concentration was determined by NanoDrop (peqlab) measurement. 
 
Phenol-Chloroform-Isoamyl alcohol extraction:  
The sample containing DNA or RNA was adjusted to 500 µl with H2O (Qiagen) and 
mixed by vortexing with 500 µl phenol-chloroform-isoamyl alcohol. Phases were 
separated by 2 min of centrifugation at 14000 rpm (Eppendorf 5424 tabletop centrifuge). 
The upper, aqueous layer was transferred to a new tube and complemented by 50 µl 3 M 
sodium acetate pH 5.2 and 1 ml 100% ethanol. After vortexing, precipitation was allowed 
at -80°C for 30 min, followed by centrifugation at 4°C, 14000 rpm for 10 min. The 
supernatant was sucked off and replaced by 750 µl 70% ethanol. After another round of 
centrifugation for 5 min at 14000 rpm, the supernatant was sucked off again and the pellet 
was left to air dry for about 10 min, then it was resuspended in 20 – 50 µl H2O (Qiagen). 
 
Restriction digest:  
Either 0.5 - 2 µg or all purified DNA from phenol-chloroform-extraction was mixed 
with 3 µl 10x buffer (NEB) as required by the enzyme, 0.3 µl 100x BSA if required by the 
enzyme, 0.5 µl enzyme 20 u/µl (NEB) and dH2O to a total of 30 µl. After incubation at 
37°C for 2 h the enzyme could be deactivated by heating to 65°C for 20 min or if necessary, 
religation could be inhibited by addition of 1 µl alkaline phosphatase (Calf Intestinal 
Alkaline Phosphatase (CIP) (NEB)) and incubation at 37°C for 45 min. Restricted DNA 
was analyzed on an agarose gel. 
 
Isolation of DNA from agarose gel:  
A Promega kit (Wizard SV Gel and PCR Clean-up System) was used for this purpose. 
The 0.5% gel was viewed under UV light and the correct band was excised as economically 
as possible to have all DNA in a small portion of gel. This gel slice was weighed, soaked in 
10 µl per 10 mg Membrane Binding solution and heated to 50°C for 10 min with 
occasional shaking. After total solubilization, the mixture was transferred to a SV 
Minicolumn placed in a Collection Tube and incubated for 1 min at ambient temperature. 
Centrifugation was performed for 1 min at full speed on a tabletop centrifuge (Eppendorf). 
After discarding the flow through, the membrane was washed with 700 µl Membrane 
Wash Solution and centrifugation like before. After addition of another 500 µl Membrane 
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Wash Solution, the column was centrifuged for 5 min at full speed. The emptied tube was 
dried with one additional minute of centrifugation. Elution was performed with 50 µl 
Nuclease-free water after the filter had been moved to a fresh 1.5 ml microcentrifuge tube. 
Following 1 min incubation at room temperature the tube was centrifuged for 1 min at 
14000 rpm. 
 
Ligation:  
Backbone DNA and insert are mixed preferably in a ratio of 1:3 molecules, starting with 
about 100 ng of vector. They were mixed with 1 µl 10x ligation buffer, 0.5 µl T4 DNA ligase 
[400 u/µl] and dH2O to a total volume of 10 µl and incubated at room temperature for 1-3 
h. A negative control for autoligation of the backbone was included where the insert DNA 
was replaced by H2O. 
 
Heat-shock transformation:  
Competent MC1061/P3 bacteria (Invitrogen) were thawed on ice. 100 µl were mixed 
with 5 µl of ligation mix (approximately 100 ng DNA) or 10 pg control plasmid, and 
incubated on ice for 30 min. The bacteria were heat-shocked in a 42°C water bath for 30 s 
and then put back on ice for 2 min. After addition of 800 µl SOC medium (Invitrogen) or 
LB, the suspension was incubated at 37°C for 1 h. 100 µl and the pellet of the 
transformation mixture were spread on agar plates + 12.5 µg/ml ampicillin and 16 µg/ml 
tetracycline and incubated at 37°C overnight or longer, if growth was very slow. 
 
Sequencing and alignment:  
Primer which bind to the pCDM8 backbone (PF 2130-2148, PR 2692-2717) were 
diluted to 5 µM in H2O and sent together with a few µl of sample DNA (approx. 1 µg) to the 
I.M.P. sequencing service (IMP, VBC, 1030 Vienna). Results were obtained by e-mail and 
sequences were aligned to normal and the reverse complement of the pCDM8 sequence 
and the ICAM-1 sequence with the program “BioEdit” 
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). 
 
Site directed mutagenesis:  
This method introduces a point mutation in a plasmid by PCR. To be able to remove the 
not mutated template, it has to be produced in bacteria with an active Dam methylase. In 
this case, MC1061/P3 E.coli were used. The forward primer ICAM_Sac1_mut_1591 (see 
primer index in section 8.2) was designed to hybridize to the sequence of ICAM-1 exactly 
on the position of the SacI restriction site except for one nucleotide: the guanine on 
position 1602 was exchanged for an adenine which resulted in the same amino acid 
glutamic acid but destroyed the recognition site of SacI. The reverse primer 
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ICAM_Sac_mut_1590b was designed to bind directly adjoining to the forward primer, not 
leaving out a single nucleotide (see Figure 3-4 for a scheme of the point mutational primer 
design).  
 
Figure 3-4. Scheme of a PCR set-up for the introduction of a point mutation in a plasmid. One 
primer encloses the site of the intended point mutation, containing a single mismatch 
nucleotide. The end of the second primer directly adjoins to the end of the first primer, leaving 
no gap in the circle after ligation of the linear PCR product. 
Replication with primers designed this way results in linear plasmids with one changed 
nucleotide compared to the template introduced by the primer. To allow the recirculation 
of the plasmid, the primers have to be phosphorylated. For that purpose 5 µl of 100 µM 
primer were mixed with 5 µl kinase reaction buffer (NEB), 2 µl 25 mM MgSO4, 1 µl 100 
mM ATP, 1 µl T4 polynucleotide kinase (NEB) and water to a final volume of 50 µl. The 
preparation was incubated at 37°C for 1 hour and the enzyme was deactivated during 20 
min at 65°C. 1.8 µl of the phosphorylated forward primer and 2.6 µl of the phosphorylated 
reverse primer were mixed with 100 ng template DNA (plasmid pCDM8-ICAM1), 5 µl 5x 
pfu polymerase buffer (Promega), 1 µl 10 mM dNTP mix (Promega), 1 µl pfu polymerase 
(Promega) and H2O to a total volume of 50 µl. The PCR program consisted of 2 minutes at 
95°C, 25 cycles of 1 min 95°C, 45 s 55°C, 22 min 72°C, followed by a final elongation step 
for 10 min at 72°C. After checking 5 µl of the preparation on an agarose gel, the original 
template was digested by addition of 2 µl of DpnI and incubation at 37°C for 1 hour. 
Finally, the linear PCR products were ligated to again form circular plasmids by mixing 2 
µl of PCR product with 0.5 µl 10x T4 DNA ligase buffer (NEB), 0.5 µl T4 DNA ligase (NEB) 
and 2.3 µl H2O and incubating it overnight at ambient temperature.  
 
 
Production of competent MC1061/P3 bacteria:  
P3 is a low copy number, 60 kb plasmid that carries the drug resistance genes for 
kanamycin (Kan), tetracycline (Tet), and ampicillin (Amp), whereas only the Kan gene is 
fully active and can be used for selection of the P3 helper plasmid. The Tet and Amp genes 
carry amber mutations which have to be suppressed to render the resistance markers 
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active. Some expression vectors, e.g. pCDM8, do not contain any resistance genes 
themselves, but the suppressor F (supF) gene. Bacterial strains transformed with both, P3 
and pCDM8, are therefore resistant to Kan, Tet and Amp. Since the rate of spontaneous 
reversion associated with the amber mutants is quite high, there should always be used the 
double selection Tet and Amp. It should be noted that the growth rate of the genetically 
modified MC1061/P3 can be quite low. 
To find a single colony which has not lost the P3 helper plasmid, a few µl of a fresh 
MC1061/P3 suspension were spread on an agar plate + 40 µg/ml Kanamycin and 
incubated overnight at 37°C. 25 single colonies were picked, numbered and patched on a 
plate + 10 µg/ml Tet, a plate with 50 µg/ml Amp and a fresh Kan plate. After incubation at 
37°C overnight, a single colony from the Kan plate was picked which did not grow on 
either Amp or Tet and used for inoculation of 5 ml LB + 40 µg/ml Kanamycin. After 
overnight growth in a 37°C shaker, 1 ml of the suspension was used for inoculation of 200 
ml LB + 40 µg/ml Kanamycin. It was further incubated until an OD600 of about 0.25-0.3 
was reached. The culture was chilled on ice for 15 min and distributed to 50 ml tubes. Also 
0.1 M CaCl2 solution and 0.1 M CaCl2 plus 15% glycerol were precooled on ice. The cells 
were centrifuged for 10 min at 3300 g at 4 °C. The supernatant was removed and the 
pellets resuspended in 4x 20ml cold 0.1 M CaCl2. Incubation for 30 min on ice was 
followed by another round of centrifugation like above. The cell pellets were resuspended 
in 12 ml 0.1 M CaCl2 solution plus 15% glycerol and distributed in 300 µl aliquots, which 
were frozen in liquid nitrogen and stored at -80°C. 
 
3.3 V33333 receptor production 
Growth of transformed DH5α1 bacteria:  
8 liter LB medium were prepared by dissolving 25 g/l LB powder in dH2O and having it 
autoclaved. After autoclavation 100 µg/ml ampicillin (Amp) were added. An overnight 
culture was prepared by inoculation from a pMALc2b-MBP-V33333-His6 transformed 
DH5α1 glycerol stock of 200 ml LB-Amp. 800 ml culture were prepared and shaken over 
night at 37°C. 100 ml were used for inoculating 1 L of fresh LB-Amp, for further growth 
the bacteria were kept at 32°C on a 130 shakes/min shaker. 
 
 
Induction of protein expression:  
After reaching an OD600 of 0.7 as determined by an Eppendorf BioPhotometer, protein 
expression was induced by adding IPTG (peqlab) to a final concentration of 0.3 mM. 
Expression was performed at 32°C over night, since slower protein expression yields 
higher quality proteins. 
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Protein isolation:  
Bacteria were pelleted by centrifugation at 4200 rpm, 4°C for 20 min in a Megafuge 
1.0R (Heraeus Insruments) centrifuge. All pellets were combined and resuspended in 150 
ml TBSC buffer (25 ml Tris buffer pH 7.5, 30 ml 5 M NaCl, 10 ml 1 M CaCl2, 935 ml dH2O 
plus 10 mM CaCl2, autoclaved). Bacteria were broken by 3x 30 s ultrasonication in a 
Bandelin Sonopuls HD200 on ice and centrifuged at 17000 rpm for 30 min in a Sorvall 
RC5C centrifuge employing a Sorvall SS43 rotor. The soluble protein-containing 
supernatant was transferred to a new tube and supplemented with 25 µl / 50 ml protease-
inhibitor Leupeptin. It was stored at 4°C over night. Ni-NTA slurry was used to pack a 
column, which was then washed with 5 column volumes TBSC (1 column volume = 10 ml) 
before applying the supernatant. Unspecific bound protein was washed away with 10 
column volumes of TBSC + 10 mM Imidazole. The V33333 receptor carries a His6-tag 
which binds specifically to Ni-NTA. It was eluted with 6 column volumes TBSC + 250 mM 
Imidazole, the first 5 ml flow through were collected separately because it could be 
expected that they still contained contaminating protein. See Figure 3-5 for the binding 
chemistry between Ni2+ and the histidines of the His6-tag and how Imidazole competes 
with the amino acid for binding sites during elution of the protein.  
 
 
Figure 3-5. Histidine residues of a His6-tag coordinated to the Ni2+ of Ni-NTA (left), and their 
replacement by 250 mM Imidazole (right). Scheme was modified from 
http://pages.usherbrooke.ca/bcm-514-bl/5e1.html. 
 
SDS PAGE:  
10 µl of each elution fraction were checked on a 15% SDS PAGE gel for content of 
receptor protein (around 68500 Da) and impurities. A 15% SDS PAGE gel consisted of a 
resolving gel (1.25 ml 4x buffer: 0.5 M TrisHCl pH 6.8 0.4% SDS, 1.25 ml dH2O, 2.5 ml 
acrylamide, polymerized with 25 µl 10% APS and 2.5 µl TEMED) and a 4.5% stacking gel 
(1.5 ml stacking gel mixture [consisting of 1,25 ml 4x buffer, 3 ml H2O and 750 µl 
acrylamide], polymerized with 25 µl APS, 2.5 µl TEMED). Samples were mixed 1:1 with a 
2x reducing sample buffer and heated to 95°C for 5 min. Constant 25 mA per gel were 
applied for running. The finished gel could be protein stained with coomassie blue by 
incubation in a staining bath for 5 min and then destaining in hot water. 
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Concentration of protein by spin column:  
The membrane of Centriprep columns (Amicon Inc.) with a molecular weight cut off 
(MWCO) of 30 kDa was wetted with TBSC and a short round of centrifugation. The 
sample was spinned at 2000 rpm, 4°C, until the desired concentration of the sample was 
reached. 
 
Dialysis including redox system:  
The dialysis tube had a MWCO of 6-8 kDa which allowed the diffusion of Imidazole. It was 
pre-wet in dH2O, one side was closed with a clamp, the sample was filled in and it was 
given some air and space before closing with a second clamp, so it would float and be able 
to expand with the influx of water. It was placed into a beaker containing 5 l TBSC buffer + 
1 mM Cystamin + 10 mM Cysteamin. The receptor needed the redox system (Cystamin –
Cysteamin) for at least 2 days at 4°C for correct folding. Dialysis was allowed for at least 3 
hours or overnight at 4°C under constant slow stirring before replacement of the buffer. It 
was repeated with fresh buffer 5 times which would give a total dilution of Imidazole of 
1:1250. 
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4 Results 
4.1 Minor group receptor expression 
For the specific attachment of HRV2 to the nanocontainer membrane a recombinant 
receptor was expressed. The recombinant MBP-V33333-His6 is a soluble, high affinity 
HRV minor group receptor construct derived from the VLDLR. The virus binding domain 
3 had been concatemerized to give 5 repeats and therefore especially high binding affinity 
and it had been attached to a MBP on the N-terminus for better solubility and a His6-tag 
for attachment to Ni2+ on the C-terminus [25]. MBP-V33333-His6 receptor was expressed 
in bacterial culture from a previously produced pMALc2b-VLDLR33333 plasmid [25] 
already transformed into Top10 E.coli. To recover the receptor protein from the 
supernatant of the broken cells, it was purified on a Ni-NTA column. NTA offers 4 metal 
ion binding sites with only little ion leaching, ensuring such tight binding of the protein 
that harsh buffers are not enough for elution. Therefore the column was washed with 
TBSC + 10 mM imidazole to remove all non-specific contaminants and eluted with TBSC + 
250 mM imidazole. Imidazole, a metal complexing agent, is a competitor of the His6-tag 
and pushes the histidines out of the Ni2+ binding site (see Figure 3-5). Eluted material was 
collected in 6 fractions which were then checked on a 15% SDS-PAGE (see Figure 4-1) for 
concentration and the presence of impurities. 
 
Figure 4-1. SDS PAGE gel showing elution fractions of MBP-V33333-His6 eluted from a Ni-NTA 
column with 250 mM imidazole. Highest 72 kDa receptor (arrow) concentration can be found 
in fraction 2, which also contains higher molecular weight material, presumably oligomers. 
The 72 kDa receptor protein was mainly found in the second fraction, but also the other 
fractions showed detectable bands of protein. Fraction 2 also contained visible amounts of 
higher and lower molecular weight impurities which are probably cellular proteins with a 
native poly-histidine-tag or oliogomers of the V33333 protein. The amount of unspecific 
proteins was considered neglectable compared to the concentration of V33333, so all 
fractions were combined and dialyzed several times against five liters of TBSC + 1 mM 
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Cystamin + 10 mM Cysteamin, a redox system, to reduce the amount of imidazole in the 
buffer to about 5.8 µM, otherwise the imidazole would have inhibited the binding reaction 
of the receptor protein to the Ni-DGS-NTA of the liposomes. The protein concentration 
was increased to 2.4 mg/ml. 
Binding capacity of the new receptor preparation to HRV2 was checked via CE. Figure 4-2 
shows the electropherograms of HRV2 and the freshly prepared MBP-V33333-His6 at 
different molar ratios. The complex of receptor and virus formed a shifted peak which 
drew matter from the peaks corresponding to its individual components. A 1:1 ratio 
consumed all receptor and gave a small peak for the complex. Application of a 1:12 ratio, 
which supposedly saturates all receptor binding sites of HRV2, reduced the peak of free 
virus strongly and at the same time produced several peaks for virus-receptor complexes, 
apparently created by complexes with differing numbers of bound receptor. The same 
pattern had already been shown by Konecsni [25]. Also a small share of unbound receptor 
appeared, this might be due to dysfunctional virus-binding sites of some receptor 
molecules. Employing an excess of receptor in a 1:18 virus:receptor ratio gave one large 
peak for the complex, probably with saturated binding sites, all virus was consumed and 
some receptor stayed unbound. 
 
Figure 4-2. Electropherograms of virus and freshly expressed receptor V33333 at different 
molar ratios, detected with UV at 205 nm in CE. BGE: 100 mM borate buffer, 10 mM Thesit, pH 
8.3; sample buffer: benzoic acid in 100mM borate buffer, pH 8.3; separation conditions: 25kV, 
20°C. Saturation of all 12 binding sites on the viral capsid requires a slight excess of receptor to 
compensate for dysfunctional molecules, at a molar ratio of 1:18 HRV2:V33333 all virus is 
saturated with receptor. 
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4.2 Major group receptor cloning 
Up to now, the nanocontainer system had only been used with the minor group virus 
HRV2 and the corresponding recombinant receptor derived from the LDLR family. Since 
there is a great functional variety between the more than 100 serotypes, especially 
between major and minor group viruses (differences are described in section 2.2.4), it is 
not possible to study just one serotype and apply the results gained from that insight on all 
other serotypes. HRV2 is used as a model for viral infection via the LDLR family of the 
minor receptor group, the totally different viral infection pathway of the major receptor 
group via ICAM-1 might be explored with HRV14 as a model. But for these studies the 
nanocontainer system has to be adapted to major group viruses, which means that the 
recombinant MBP-V33333-His6 receptor has to be replaced by a recombinant ICAM-1 
receptor. ICAM-1 consists of 5 Ig-like domains, a transmembrane domain and a 
cytoplasmic domain. For employment of the major group receptor ICAM-1 in the 
nanocontainer system and in other experiments, it is necessary to make the receptor, 
originally a hydrophobic transmembrane protein, soluble by cutting off the cytoplasmic 
and transmembrane domains and adding a His6-tag for attachment of the receptor to 
nickel-DGS-NTA. The gene encoding the major group receptor ICAM-1 was purchased 
from Addgene. It came inserted in the plasmid pCDM8, a 4356 bp vector (see Figure 4-3).  
 
The binding site is situated in the Ig-like domain 1, the full 5 domains keep the virus at 
quite a distance from the plasma membrane of the host cell and would do so with the 
liposomal surface in the nanocontainer system. Hence it was decided to produce the 
receptor in two distinct versions, once full length consisting of all 5 Ig-like domains, and 
Figure 4-3. 
Plasmid map of 
pCDM8-ICAM1 
as provided by 
the plasmid 
source Addgene. 
The ICAM-1 
encoding gene is 
flanked by two 
XbaI restriction 
sites and has a 
total length of 
1800 bp. Map 
provided by 
Addgene Inc., 
Cambridge, MA, 
USA. 
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another version containing just the Ig-like domains 1 and 2. The shortened receptor was 
intended to keep the virus at a shorter distance from the liposomal membrane and 
therefore facilitate the RNA transfer into the nanocontainers, in case the full length 
receptor would function only weakly. In vivo, ICAM-1 undergoes several posttranslational 
modifications. The glycosylations are important for the hydrophilicity of the receptor. The 
recombinant receptors have to be produced in eukaryotic cells to render the 
posttranslational glycosylation possible, prokaryotic cells have no mechanism for that. 
Instead of glycosidic residues it is also possible to add a maltose binding protein (MBP), 
which aids the solubility of the receptor as well. However, it has to be taken care that the 
MBP does not inhibit the receptor-virus interaction. Adding it to the recombinant ICAM-1 
Ig-1 domain would most certainly interfere with viral interaction, therefore it can only be 
attached during expression in bacterial suspension and has to be cleaved off via a factor Xa 
cleavage site before applying it to the nanocontainer system or subjecting it to other virus-
interacting experiments. 
Therefore, two possibilities for receptor protein expression were considered: fast 
prokaryotic expression of the protein adjoined to MBP in bacterial suspension and 
subsequent cleavage of MBP or eukaryotic expression of the receptor protein in 
mammalian cell culture. It was thus intended to clone 4 different ICAM-1 receptors: 
ICAM-D5-His6 for expression in eukaryotic cells (see Figure 4-4 A), ICAM-D2-His6 also for 
expression in eukaryotic cells (Figure 4-4 B), MBP-ICAM-D5-His6 for expression in 
bacteria (Figure 4-4 C) and MBP-ICAM-D2-His6 also for expression in bacteria (Figure 
4-4 D). Each expression route made a different cloning strategy into different vectors 
necessary. 
 
Figure 4-4. Schemes of the truncated ICAM-1 genes ready for integration into a plasmid for 
expression in eukaryotic cells (A+B) and in prokaryotic cells (C+D). A+B are flanked on both 
sides by restriction sites for XbaI and short genome extensions for proper enzyme function. 
The 3’ ends are linked to a His6-tag and a stop codon. C+D are flanked by a SacI site on the 5’ 
end and a KpnI site on the 3’ end. The SacI site is situated within MBP, hence it is followed by 
the C terminus of MBP which can be cleaved off of the ICAM1 protein via an Xa cleavage site. 
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The SacI site within ICAM1 domain 5 is mutationally silenced. The 3’ ends are also linked to a 
His6-tag and a stop codon. 
bacterial expression strategy: 
For protein expression in bacteria, the intention was to use the expression vector 
pMALc2b, the same vector that had been successfully used for V33333 expression and 
already contained the DNA encoding MBP (note Figure 4-5 for an overview of the cloning 
steps).  
 
 
To cut out the gene for V33333 of the vector pMALc2b, the enzyme SacI would have been 
the best suitable, except for another SacI restriction site present within the ICAM-1 gene. 
Therefore the first step was to introduce a translational silent point mutation into this SacI 
Figure 4-5. Scheme of the 
cloning strategy for truncated 
ICAM-1 expression in bacterial 
cells. Primers were 
phosphorylated prior to 
mutational PCR, the template 
plasmids were digested after 
SacI restriction site mutation 
with DpnI. Linear 
mutagenized amplicons were 
religated and the plasmids 
transformed into MC1061/P3. 
Single colonies were picked 
and used for Mini prep 
plasmid DNA isolation. 
Domains 1-2 and 1-5 of the 
SacI mutated ICAM-1 were 
excised and amplified via PCR 
with primers which added a 
SacI restriction site and part 
of MBP on the 5’ end and a 
His6-tag and a KpnI 
restriction site at the 3’ end 
and the DNA was purified in a 
chloroform-phenol-
extraction.  
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enzyme recognition site GAG CTC. GAG encodes the amino acid glutamic acid, which is 
also encoded by GAA, hence the second guanine, on position 1602, was exchanged for an 
adenine which resulted in the same amino acid, glutamic acid, but destroyed the 
recognition site of SacI. Primers were designed specifically for that purpose: the forward 
primer spanned 15 nt upstream and 15 nt downstream of the mutation target to allow tight 
binding despite the mismatch (ICAM_Sac1_mut_1591), the reverse primer was placed in a 
way that its first nucleotide directly connected to the first nucleotide of the forward 
primer, leaving no gap between them (ICAM_Sac1_mut_1590b) (Figure 3-4). Primers 
were phosphorylated to later allow the ligation of the produced linear plasmid and used in 
a mutagenizing PCR. Template plasmids were digested with DpnI to ensure that only 
mutagenized ICAM-1 would be used in the further cloning steps. Linear plasmids were 
recircularized with DNA ligase and transformed into MC1061/P3 E.coli. Several colonies 
were picked from the Amp + Tet plate and used for Mini preps. Isolated DNA was checked 
via SacI restriction digest to ensure that the SacI site within the gene for ICAM-1 was 
inactive. Figure 4-6 shows the result of the restriction digest of the mutated clones and the 
non-mutated starting plasmid for comparison. Only one of the clones (lane 5) had been 
cut twice and hence gave bands at 4500 and 1650 bp like the non-mutated plasmid, all 
other clones had only been restricted once, proving that the mutation of SacI within 
ICAM-1 had been successful. 
 
Figure 4-6. Agarose gel of 6 clones containing a SacI mutated pCDM8ICAM1 plasmid and a 
non-mutated control plasmid, digested with SacI. The total plasmid size was 6150 bp, all clones 
except one met the expected size since they had only 1 SacI restriction site left. The non-
mutated control (lane 7) and clone 5 were cut twice by SacI and gave the 2 expected bands for 
1650 and 4500 bp. Clone 3 was used for further experiments. 
 
Specifically designed primers were used in PCR to excise domains 1-2 and 1-5 of clone 3 
ICAM1mutSacI. The forward primer also added a SacI restriction site and the C-terminal 
part of MBP until cleaving factor Xa (see Figure 4-4, C and D). This part will be lost when 
V33333 is cut from the vector pMALc2b with SacI and KpnI. Adding it directly to the new 
insert will restore the full MBP and the cleavage factor upon ligation of the insert into the 
truncated vector. Reverse primers added a His6-tag and a stop codon to the end of the 
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truncated ICAM-1 and introduced a restriction enzyme recognition site for KpnI. The 
amplicon was purified via Phenol-Chloroform-Isoamylalcohol extraction.
At that point the bacterial expression strategy was abandoned in favor of the eukaryotic 
expression strategy, which was considered to have a higher probability of success. In case 
the eukaryotically expressed receptor proves to be dysfunctional or not soluble enough, it 
is still possible to return to the bacterial expression strategy and continue the cloning of 
that receptor construct by digesting the SacI-mutated ICAMmutSacI (isolated and 
amplified via PCR with the primer forward ICAM_SacI_Xa_401 and the primers reverse 
ICAM_D5_KpnI_1759b or ICAM_D2_KpnI_898b, to gain a full length and a shortened 
version of ICAM-1, respectively) and the pMALc2b-MBP-V33333-His6 backbone with the 
enzymes SacI and KpnI. The vector pMALc2b-V33333 and the inserts ICAM1mutSacI-D2 
and ICAM1mutSacI-D5 are ready for further usage. After separating the backbone 
fragment from the old insert via an agarose gel, it can be ligated with the inserts and 
amplified in Top10 E.coli. After confirming a correct clone via sequencing, the plasmid can 
be used for protein expression in bacteria. 
 
eukaryotic expression strategy: 
It was planned to excise the desired domains of the ICAM-1 gene from its vector by 
PCR, add a His6-tag, a stop codon and new restriction sites in the same process and 
religate it back into pCDM8 for larger scale replication in E.coli. The purified plasmid 
could then be used for protein expression in eukaryotic cells. The sequence of the cloning 
steps performed is depicted in Figure 4-7. 
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First, primers were designed for the excision of the domains 1-2 and 1-5. Primer 
sequences can be found in the primer index (see 8.2). Requirements of well designed 
primers include a minimal length of 15 binding nucleotides, a melting temperature of at 
least around 60°C, a Guanine or Cytosine as last nucleotide and no unspecific binding, 
neither to the template nor its reverse complement strand. Binding of the primer was 
checked via the program “Bioedit Sequence Alignment Editor” (available at 
http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The forward primer consisted of 4 
nucleotides in addition to the recognition sequence for the XbaI restriction enzyme and a 
pCDM8 complementary region at the beginning of the ICAM-1 gene 
(ICAM_pCDM8_2197) (see primer index 8.2). Two different reverse primers were 
necessary for cutting once after domain 2 and another time after domain 5. These primers 
consisted of an ICAM-1 complementary region at the end of domain 2 and 5, respectively, 
plus a His6-tag, a stop codon, the XbaI restriction site and some random nucleotides as 
extension for the enzyme binding (ICAM_D2_Xba1_898b, ICAM_D5_Xba1_1795b). 
Figure 4-7. Scheme of the cloning 
strategy for truncated ICAM-1 
expression in eukaryotic cells. The 
desired domains 1-2 and 1-5 of ICAM-1 
were excised and amplified with 
primers which added a His6-tag and 
new XbaI restriction sites, the DNA was 
purified via chloroform-phenol-
extraction. In parallel, the vector 
pCDM8 was isolated with XbaI and 
dephosphorylated to prevent auto-
ligation of the empty vector. D2 and D5 
inserts were ligated with the vector and 
transformed into competent 
MC1061/P3. Single colonies from the 
agar plate were used for Mini preps, 
after screening them by restriction 
digestion and PCR, sequencing of the 
insertion area allowed the identification 
of correctly cloned plasmids which were 
then amplified in a Midi prep to have 
sufficient material for transfection of 
cells. 
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After excising and amplifying the truncated ICAM-1 genes via PCR, the DNA was purified 
twice via Phenol-Chloroform-Isoamylalcohol extraction and then treated with XbaI 
enzyme to get sticky ends. Also, 2.3µg of the pCDM8ICAM1 vector were treated with XbaI 
to produce an empty backbone, which was then treated with Alkaline Phosphatase for 
prevention of autoligation. To separate the backbone from the full ICAM1 insert, it had to 
be applied to an agarose gel, so the band for the backbone could be excised and the DNA 
purified. The empty backbone pCDM8 and the truncated ICAM1 were religated via the 
XbaI sites. After heat-shock transformation of the plasmid into competent MC1061/P3, 
cells which contain the helper plasmid P3, numerous colonies appeared on the Amp + Tet 
plates. Mini preps of several colonies were prepared and the plasmids were checked after 
XbaI restriction digestion on an agarose gel to see if the plasmid really contained the 
desired insert. Bands, in particular the one for the insert, were hardly visible due to the 
low amount of DNA, so the presence and length of inserts was additionally checked via 
PCR. Primers, which had been designed to bind to pCDM8, flanking the ICAM1 inserts 
about 50 nt upstream and downstream of the XbaI restriction sites, respectively, 
(pCDM8_2130sequ, pCDM8_2692sequ_b), were used.  
 
Figure 4-8. Agarose gel of ICAM1-D5 and ICAM1-D2 inserts from several clones amplified with 
PCR primers whose amplicon spans the whole inserted region. ICAM1-D5 shows the expected 
insert size of approx. 1600 nt (lane 1); there was no insert in the clone 1 of ICAM1-D2 (lane 2), 
the clones 2 and 4 showed the expected insert size of approx. 750 nt (lane 3 and 5), clone 3 
contained a double-sized insert (lane 4). 
Figure 4-8 illustrates that some plasmids showed the correct insert length of 1600 bp for 
ICAM1-D5 (lane 1) and 750 bp for ICAM1-D2 (lanes 3 and 5). Lane 4 contains a band for a 
much longer product with double the size of ICAM1-D2. Since XbaI was used on both 
sides, several inserts could ligate as concatemers into the backbone. Plasmids with the 
correct insert size were sent to sequence analysis with the same primers as for the above 
mentioned control PCR (pCDM8_2130sequ, pCDM8_2692sequ_b). Pairwise alignment 
of the sequenced plasmids with pCDM8 and ICAM1 in “Bioedit” made the exact cloning 
product visible. Another problem caused by the two XbaI sites was found: the insert could 
also ligate in the reverse direction (Figure 4-8 lane 3). Luckily, one clone each was found 
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(ICAM1-D5 from lane 1 and ICAM1-D2 from lane 5) which proved to carry the correct 
insert (check 8.3.2 and 8.3.3 for sequences) and could be further used. Additionally, a 
point mutation in the ICAM-1 gene was identified (see plasmid sequence of pCDM8-
ICAM1-D5-His6 in section 8.3.3 for position): many published sequences (e.g. NCBI 
accession number NM_000201) have an A at the questionable position, sequencing of the 
cloning product and the first plasmid sample isolated from the purchased pCDM8ICAM1 
plasmid resulted in a G at the same position. Probably, already the originally purchased 
plasmid pCDM8ICAM1 had carried that mutation. The original AA coding triplet GCA is 
translated into an alanine, the mutated tripled GCG does not change the translational 
product. Although most published sequences refer to an adenine, also sequences 
containing the guanine have been published [37] (EMBL X06990). Since it was a silent 
mutation, no further attention was paid to it. 
A total of 315 µg of the plasmid pCDM8-ICAM1-D2-His6 and 303 µg of the plasmid 
pCDM8-ICAM1-D5-His6 were produced via amplification in MC1061/P3 and purified to a 
260/280 absorbance ratio of above 1.8 which is a purity high enough for transfection of 
eukaryotic cells (measured by NanoDrop). Maps are depicted in Figure 4-9 and the 
sequences can be found in the appendix 8.3. Transfection into eukaryotic cells like CHO 
can be either transient to check the functionality of the receptor or stable to directly go for 
high yield production. 
 
 
Figure 4-9. Plasmid maps of the cloned ICAM1-D5 (left) which is cut off after the domain 5 and 
ICAM1-D2 (right) which is cut off after the domain 2 of ICAM-1 and have therefore lost their 
transmembrane and cytoplasmic regions. Both have a His6-tag attached to the 3’ end and are 
flanked on both sides with an XbaI restriction site. 
Due to time limitations and focus on experiments with minor group viruses further 
conduction of soluble ICAM1 expression had to be halted. 
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4.3 RNA transfer through liposomal membranes 
nanocontainer construction: 
For production of nanocontainers, 5 µmol in chloroform solubilized lipids consisting of 
20 mol% POPC, 20 mol% PE, 20 mol% SM, 30 mol% cholesterol and 10 mol% Ni-DGS-
NTA, in case of flotation experiments also 1 mol% NBD-PC was added for each 
preparation. The dry lipid film was rehydrated with 300 µl RT mix for 2 hours to give a 
multilamellar vesicle (MLV) stock of 17 mM total lipid concentration.  
The MLV stock was subjected to extrusion through a polycarbonate membrane with 
400 nm pore size. Passing it through 41 times, the liposomes were ripped apart and 
reformed at diameter sizes ≤ 400 nm as large unilamellar vesicles (LUV). The use of 
freshly prepared lipid stocks and elimination of air bubbles inside the syringes ensured 
good quality of the liposomes. 
Prior to their application, LUVs had to be purified to remove non-encapsulated RT mix. 
This ensured that only RNA which had been transferred across the liposomal membrane 
was detected, RNA released to the outside buffer could not be transcribed into cDNA and 
was therefore not detected. For that purpose, liposomes were passed two times through a 
mini size exclusion chromatography column which retained ions and small molecules and 
allowed the liposomes to pass through with the buffer. This resulted in dilution of the 
original LUV stock, especially when Sephadex G-50 medium was used for the mSEC, G-50 
fine grade caused a little less dilution. Dilution was standardized at 1:4. The size and shape 
of the purified nanocontainers was checked in EM and is shown in Figure 4-10. All visible 
Figure 4-10. Nanocontainers 
consisting of 20 mol% POPC, 20 
mol% PE, 20 mol% SM, 30 mol% 
cholesterol and 10 mol% Ni-DGS-
NTA, filled with RT mix, extruded 
to 400 nm and purified with mSEC 
to exchange the outside buffer to 
50 mM Tris 80 mM NaCl pH 8.3. 
TEM picture was taken at 36k 
magnification; size bar = 200 nm. 
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liposomes are about 400 nm or smaller, confirming the efficiency of the extrusion. Also 
the liposomes appear to be intact and of a healthy round shape. 
 
nanocontainer decoration with receptor:  
To allow specific attachment of minor group HRVs to the liposomal membrane, the 
nanocontainers have to be decorated with receptor prior to the addition of virus. For each 
sample, purified liposomes were decorated with the recombinant receptor MBP-V33333-
His6. It is derived from the VLDLR by taking the virus binding domain 3 and cloning it five 
times next to each other, flanked by a His6-tag for Ni-DGS-NTA attachment and a maltose 
binding protein (MBP) for better solubility [24, 38]. Ni-DGS-NTA had a share of 10 mol% 
of the total lipid amount, therefore one sample preparation contained 6.4 nmol Ni-DGS-
NTA lipid. 36 pmol receptor were added to the 6.4 nmol Ni-DGS-NTA lipid. Assuming 
homogenous distribution of the Ni-DGS-NTA lipid across the membrane bilayer, only half 
of it is presented on the outer liposomal surface, i.e. 3.2 nmol. Consequently, there is 
almost 90 times more Ni-DGS-NTA present than receptor, ensuring that almost all 
receptor molecules are bound to the nanocontainer surface. Free receptor is believed to 
stabilize the virus [39]. When the virus is already bound to liposomes the receptor 
stabilizes the virion and inhibits the RNA release and transfer across membranes. In 
solution, the free receptor can saturate all viral binding sites and thereby not only inhibit 
the uncoating process, but also hinder the attachment of the virion to the liposomal 
membrane, preventing any possibility of RNA transfer across the membrane. By strongly 
outnumbering the receptor with Ni-DGS-NTA, this inhibitory effect should be kept to a 
minimum.  
 
nanocontainer decoration with virus: 
Minor group rhinovirus HRV2 uses LDLR family receptors such as the VLDLR for 
attachment to the host cell, in the here performed experiments the VLDLR derived 
recombinant receptor V33333-His6 was employed. In theory, each virion attaches to up to 
12 receptor molecules [25]. Even though it will not use all of these sites it should be bound 
tightly to the host cell or liposome by one or several receptors. If the virion is using several 
attachment sites it might fold the membrane around itself, causing invagination. Upon 
attachment and beginning conversion, the viral particle is thought to insert VP4 and the 
N-terminus of VP1 into the membrane. Numerous virions doing that next to each other 
might cause a strong perturbation of the liposomal membrane which could lead to holes 
and leakage (see discussion 5.3). If too few virions are applied the sensitivity of the assay 
will not be high enough to detect any RNA at all. Therefore, it is very important to 
elucidate the best virus concentration which is a trade-off between transferring as much 
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RNA into the liposome as possible and not ripping it apart while doing so (see virus 
dilution series below). Orienting experiments indicated that about 5.5 x 1010 viral particles 
(corresponds to 91 fmol) had to be used in one sample to get a strong signal by standard 
RT-PCR. 
Since every virus preparation has a different concentration and different percentages of 
dead and viable virus particles, probably also different amounts of impurities, this 
concentration has to be determined experimentally with every new virus preparation used. 
Normally, concentrations between 10 and 500 fmol virus per 64 nmol lipid gave an RT-
PCR signal. Virus was diluted in TrisNaCl buffer to the desired concentration, added to the 
receptor-decorated liposomes and incubated at room temperature for 30 min. The product 
could be checked in EM. Figure 4-11 shows the high concentration of virus in a standard 
RT-PCR sample. A lot of virus is denatured, a process which happens most probably 
during the adsorption of the sample on the grid for EM. 
  
trigger of RNA release:  
During natural infection, rhinovirus virions release their RNA into the cytoplasm of 
their host cell upon acidification of the endosome they used for entering the cell [40]. That 
mechanism can also be employed in vitro to generate 80S particles. Exposure of native 
HRV2 to a pH at 5.4 for 15 min resulted in empty virus capsids (80S particles) and 
externalized RNA [29]. In experiments presented here the pH was lowered by addition of 
1M NaAcetat pH 5.0 which resulted in a pH of 5.4 in the sample. Prior experiments had 
shown that 15 min at pH 5.4, a condition comparable to that prevailing in the interior of 
Figure 4-11. Standard 
nanocontainer system sample: 
purified nanocontainers 
decorated with receptor and virus 
(64 nmol lipid, 36 pmol receptor 
and 91 fmol virus). HRV2 is bound 
to the liposomal membrane. 
Native virus appears as well 
defined white 30 nm large dot. The 
high amount of broken virus 
particles (grey dots with 
undefined border, “popcorn”) is 
probably caused by the adsorption 
of the sample to the grid for TEM 
imaging. Picture was taken at 36k 
magnification; size bar = 200 nm. 
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late endosomes, are enough to convert most virions into 80S particles (Pickl-Herk, A., 
unpublished data). In vitro it is also possible to trigger the RNA release at elevated 
temperature. 10 min at 56°C convert 150S particles of HRV2 to empty 80S particles, given 
the virus sample is not too concentrated, since a high virus concentration inhibits the full 
conversion and stops at the intermediate 135S particle [41]. Both methods, pH lowering 
and high temperature, can be used for triggering the RNA transfer through the liposomal 
membrane, although it has been found that the pH trigger gives rise to a stronger signal in 
RT-PCR (data not shown) and is therefore not only more efficient but also the physiologic 
trigger. After the 15 min at low pH, the samples were reneutralized with 1 M NaOH, except 
when the sample was intended to be analyzed by EM. Electron microscopy pictures show 
that the virions stay attached to the liposomes as empty particles after triggering and do 
not leave the endosomal membrane before reneutralization (see Figure 4-12). The RNA 
transfer itself does not need the reneutralization, it is completed during the low pH 
exposure, but reneutralization should ensure that no pH change inhibits the following RT 
reaction for detection of luminal RNA. 
 
Figure 4-12. Nanocontainer system sample (64 nmol lipid, 70 pmol V33333, 91 fmol HRV2) 
after 15 min at pH 5.4. Most virus particles are converted to 80S particles (light shell with dark 
core), only very few are still native (full light). TEM picture was taken at 36k magnification; 
size bar = 200 nm. 
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reverse transcription without DTT: 
Normally, a reverse transcription mixture consists of H2O, 5x first strand buffer, 
reverse primer, dNTP mix, DTT, RNA template, RNasin and reverse transcriptase. For RT 
liposomes (nanocontainers) this mixture was added to the dried lipid film during liposome 
production for hydration of the lipid film so liposomes encapsulate the RT mix. 
Unfortunately, it was noticed that the addition of the mix to the dried lipids POPC, PE, 
SM, Ch and Ni-DGS-NTA caused a change of color from milky-colorless to orange-brown. 
To find the responsible component they were added one after the other instead of 
altogether. The color change happened immediately after the addition of DTT. In a 
separate experiment DTT also changed the color of NiCl2 at a slightly alkaline pH. DTT is 
normally added to break the disulfide bonds of RNases for inactivation and protect the 
reverse transcriptase from oxidation. Since the final mix also contained RNasin to 
inactivate ribonucleases, it was decided to try to omit the DTT in the RT mix. No adverse 
effect was found, the signal for transcribed RNA in RT-PCR was as strong without DTT as 
with (see Figure 4-13) in an RT mix sample without membranes. 
 
 
controls included in RT-PCR: 
Once it was found that DTT gave adverse reactions with Ni-DGS-NTA, but could be 
omitted without reducing the efficiency of the RT reaction, the nanocontainers were 
produced with the modified RT mix. After receptor and virus decoration, the encapsulated 
RT mix without DTT was tested for a signal for transferred RNA in RT-PCR (see Figure 
4-14, lane 1). This reproducible signal showed that the minimal requirements for RNA 
transfer were met in the model system set-up. Further characterization of the 
nanocontainer model system for viral infection required the implementation of several 
controls. Necessity of different components of the system and steps of the RNA transfer 
were checked by omitting or changing them. See Figure 4-14 for the RT-PCR signals of the 
following controls and compare them to the standard sample on lane 1. 
Figure 4-13. Agarose gel of by PCR 
amplified RT products transcribed 
in reaction mixtures with (+) and 
without (-) DTT. Both yielded 
strong signals at the expected 200 
bp, the RT reaction is not 
dependent on the presence of DTT. 
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To make sure that no contamination of the sample components with traces of nucleic acids 
would give a false positive signal, one sample was included without any virus. Receptor 
decorated liposomes were triggered by pH treatment and subjected to RT and PCR 
reaction. Any signal seen on the agarose gel was considered to be background. Negative 
control: no virus (Figure 4-14, lane 3) shows that the nanocontainer system does not give a 
signal without added virus. 
RNA transfer takes place in vivo inside late endosomes following exposure to a low pH 
of about 5.6 – 5.4 [42].  This is mimicked in the nanocontainer system by lowering the pH 
of the liposome surrounding buffer to 5.4 with 1 M NaAc pH 5.0 for 15 min after virus was 
bound to the receptor. To show the necessity of that trigger for RNA transfer into the 
liposomes, it was omitted in a control sample. Since the RNA transfer was not induced, 
there was also no signal seen on the agarose gel. Negative control: no trigger (Figure 4-14, 
lane 2). A comparable RNA releasing effect is reached by heating the diluted virus to 56°C 
for 15 min, but a pH trigger is closer to the in vivo situation of RNA release and was 
therefore chosen for the experiments performed here. 
Nanocontainers are supposed to only allow transcription of cDNA in their RT mix filled 
lumen, but not outside. That way, only RNA that had been transferred across the 
membrane will be detected. Disrupted liposomes will not allow production of cDNA. 
Components of the RT mix will leak into the surrounding and are therefore missing inside 
and buffer from the outside will flow into the liposomes and dilute the RT mix. Addition of 
Triton-X 100 to 1% final concentration disrupts all liposomes and therefore prevents 
Figure 4-14. Agarose gel 
depicting RT-PCR signals for 
transferred RNA in 
nanocontainer system 
samples. Nanocontainer 
composition as in Figure 4-10, 
RT mix was prepared without 
DTT. Decoration was done 
with 36 pmol receptor V33333 
and 360 fmol HRV2 (1.2 x 108 
TCID50). RNA release was 
triggered for 15 min at pH 5.4. 
Standard sample on lane 1, 
controls with no RNA release 
trigger (lane 2), no virus (3), 
no receptor (4), permeabilized 
nanocontainers with Triton X-
100 (5), nanocontainers not 
subjected to mSEC purification 
(6) and an RT mix sample 
without nanocontainers (7). 
For a detailed description of 
the controls note the main text.  
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cDNA production resulting in no PCR product on the agarose gel. Negative control: 
TritonX (Figure 4-14, lane 5) proves that only intact nanocontainers are capable of cDNA 
transcription. If they break apart or the RNA is not transferred into their lumen, the RNA 
will not be transcribed on the outside. 
In vivo, HRV2 binds to its receptor and is subsequently taken up by the host cell into 
endosomes. Following the pH decrease, the virion detaches from the receptor and is 
handed over to the endosomal membrane [43], through which it releases its RNA into the 
cytosol. Since the liposomes are mimicking the endosome, it is thought that a receptor is 
necessary to bring the virus close to the membrane before the trigger. The receptor 
concentrates the virus on the nanocontainers by fishing it from the exterior buffer and 
holding it close to the membrane. Therefore, when omitting the receptor, no cDNA should 
be produced because not enough virus particles are bound by chance to the membrane 
when triggered. However, corresponding experiments still showed strong signals. 
Negative control: no receptor (Figure 4-14, lane 4) gives a strong signal for transferred 
RNA. This can be explained by the small sample volume of a standard RT reaction which 
causes high concentration of liposomes and virus in the sample (visible in Figure 4-12) 
which increases the probability of virus residing in close proximity of a liposomal 
membrane at the moment of receiving the trigger for RNA release. Curry et al. [44] 
showed infection of CHO, murine L and HeLa cells by poliovirus 135S particles without 
receptor, because 135S particles are hydrophobic and therefore attach to the membrane 
even without receptor if they are close in the moment of conversion. By externalizing VP4 
and the N-terminus of VP1, the 135S particle become hydrophobic and attach to a 
membrane in close proximity where they can release their RNA into the lumen of the cell.  
As demonstrated via flotation experiments, native HRV2 is not able to bind to the plain 
liposomal membrane by itself. As shown below, receptor is necessary to stably bind the 
virus to the liposome so that it co-flotates with the liposomes in a sucrose step gradient. 
When no receptor is present, free native virus and 135S subviral particles, which had not 
been formed in the presence of the lipid membrane, stay at the high density bottom of the 
gradient, separated from the liposomes. It is not absolutely mandatory to use the receptor 
for standard RT-PCR experiments in a small total sample volume of 20 µl, since the 
virions are close enough to the membranes to bind upon conversion to 135S during low pH 
exposure. Diluting the sample 10 fold should reduce the probability of close contact by 
coincidence, but makes the precipitation of cDNA prior to PCR necessary. The small 
amounts of DNA are easily lost and reproduction of a signal from receptor decorated 
liposomes in contrast to no signal from plain liposomes was difficult. Therefore, the 
function of the receptor to concentrate the virus on the liposomal membrane before 
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triggering the RNA release could not be shown unequivocally, although it is definitely 
necessary for tight binding of the native virion. 
One control sample was included in every run and consisted of all components 
necessary for reverse transcription, in other words it was a fresh RT mix not encapsulated 
in liposomes. Triggering RNA release in that sample allowed for 100% cDNA 
transcription, because no transport across membranes was necessary, all released RNA 
could be transcribed. In the used set-up, the detection limit was found to be at 
approximately 105 virions per RT sample. This sample allowed monitoring of the 
functionality of the RT and PCR reactions, in case it failed to give a signal there was a 
problem with the RT or PCR, which explained any simultaneously failed samples. Positive 
control: RT mix (Figure 4-14, lane 7). 
To control the functionality of the encapsulated RT mix without the necessity of RNA 
transfer the purification step on a size exclusion chromatography column was left out. This 
resulted in a sample which had the concentrated RT mix not only inside the 
nanocontainers, but also on the outside. When virus was triggered in that sample, it was 
not necessary that it was bound to the liposomes and that the RNA was transferred into 
the liposomal lumen. RNA release somewhere in the sample volume was sufficient to 
make cDNA transcription possible and therefore resulted in a signal on the agarose gel. 
Only if the RT mix was not functional, for example due to aged transcriptase, the sample 
would fail to give a signal. In that way it was possible to exclude the risk of interpreting no 
signal as the result of no RNA transfer into the liposomes. Positive control: no mSEC 
(Figure 4-14, lane 6) ensured that the encapsulated RT mix worked properly. The 
saturated signal was comparably to the positive control on lane 7, since in both controls all 
RNA released from the virus somewhere in the sample could be transcribed into cDNA. 
This control showed no decline of enzyme activity due to storage, indicating that the aging 
of the enzyme was not a very fast process. Therefore nanocontainers could be stored for 
several days up to weeks without losing their functionality. 
 
virus dilution series:  
Absolute values of cDNA production were subject to a strong variation depending not only 
on directly influenceable parameters like pipetting accuracy but also on parameters which 
are difficult to control like  the age of the liposomes or the virus preparation used. 
Especially the aging of the enzyme reverse transcriptase, normally demanding storage at -
20°C but inside the liposomes it can only be kept at 4°C, had a big influence. Freshly 
prepared liposomes always gave the strongest signal which decreased with every day the 
liposomes grew older until it became not only weak but also unreliable. Nevertheless, the 
general picture was reproducible, i.e. some samples with a middle virus concentration 
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gave a stronger signal compared to higher and lower virus concentrations of the same 
dilution series experiment. A dilution series of virus with constant amounts of lipid and 
receptor was repeated many times and revealed a consistent trend. Two gels are shown 
which were produced on consecutive days (Figure 4-15).  
 
Figure 4-15. Two dilution series of virus in RT-PCR samples of the nanocontainer system. 
Signal intensity on the agarose gels was quantified with ImageJ. Note the different virus 
dilutions in A and B, the first including a sample with 18 fmol virus which results in a shoulder 
of the decreasing slope which cannot be found in the dilution series B. 
 
Although their signal intensity is quite different, they share the general pattern: no signal 
in the first lane with concentrated virus, then increasing signal until a peak is reached in 
the third lane with 91 fmol virus and then decreases again until background intensity. The 
agarose gel band intensity can also be quantified with ImageJ to give figures which are 
easier to compare and interpret. The curves given in Figure 4-15 allow the easy 
identification of the lane with the strongest signal for RNA transfer. Notably, this is not 
the lane with the highest virus concentration which would be expected to transfer the most 
RNA copies. Too many viral particles seem to decrease the cDNA transcription efficiency. 
A known RT reaction inhibiting effect is the dilution of the RT mix, as it happens in 
nanocontainers treated with the detergent Triton X. The insertion of many viral proteins 
in close proximity to each other could cause perturbation of the lipid bilayer, resulting in 
holes which allow the dilution of the encapsulated RT mix with buffer from the exterior. 
Although a lot of RNA is transferred across the membrane, the diluted RT mix is not able 
to transcribe it into cDNA and as a result it is not detected. Below a certain threshold of 
virus concentration this negative effect of the virus on membrane stability is negligible. 
The signal intensity from intact nanocontainers for detected RNA is directly related to the 
amount of applied virus, i.e. the signal intensity decreases depending on the dilution of the 
virus. 
 
conversion of native particles to 135S: 
Controls for the nanocontainer system showed RNA transfer without receptor 
mediating the attachment of virus to the liposomal membrane. It is believed that this is an 
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effect of the small sample volume which causes high concentration of viral particles and 
membranes, increasing the probability of virus residing in close proximity of a membrane 
when RNA release is triggered by acidification. Upon pH reduction the viral particle 
undergoes structural changes which result in the formation of 135S subviral particles with 
released VP4 and externalized VP1 N-terminus. These hydrophobic peptides are believed 
to insert into a membrane and allow the RNA transfer across the lipid bilayer. This would 
make the receptor dispensable for RNA transfer if the viral particles are close to a 
membrane when triggered. To study 135S particles, they have to be produced in vitro 
without fully converting the viral particle to non-infectious 80S particles. 
Native virus particles can be converted to 135S particles by heating the concentrated 
virus for 10 min to 56°C, either in a heating block or a water bath. Conversion can be 
confirmed via CE, depicted in Figure 4-16, which shows a large peak for 135S and only a 
small peak for the remaining native particles. Viral protein is detected at 205 nm, RNA at 
260 nm; if peaks show up at both wavelengths at the same time in a virus sample, it can 
only mean native particles or 135S, because 80S particles have lost their RNA  [41]. 
 
 
Figure 4-16. Electropherograms produced with UV detection of HRV2 run in CE. Blank 
contained DMSO and benzoic acid as migration markers. Concentrated HRV2 was heated to 
56°C for 10 min and its conversion to 135S particles was confirmed in CE, where the viral 
protein can be detected at 205 nm and the viral RNA at 260 nm. A small peak for native 
particles remains, but most virus particles are converted to 135S. Spikes probably indicate 
aggregation of virus particles during conversion. BGE: 100mM borate buffer, 10mM Thesit, pH 
8.3; separation conditions: 25kV, 20°C. 
Since no detectable peak for 80S particles appeared in CE, it can be concluded that the 
conversion stopped at 135S particles like expected. These particles could be used for the 
following flotation experiments to determine the binding capacity of 135S particles to 
plain liposomes. 
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separation of unbound virus from nanocontainers via flotation:  
When preparing samples in the way described above, by just adding nanocontainers, 
receptor and virus together, one question remains unanswered: how much of the virus is 
really bound to the liposomes and how much is residing in the buffer without being able to 
transfer its RNA into the liposomal lumen? Performing the RT in the negative control 
without receptor resulted in a strong positive signal for cDNA production (see Figure 4-14, 
lane 4). One might believe that the receptor plays no role at all in the nanocontainer 
system and could be left out. To show the necessity of receptor for tight attachment of 
virus to the liposome, flotation in a sucrose step gradient was employed as the method of 
choice to separate unbound virus from the liposome. The position of the liposomes could 
be determined by fluorescence measurement with the Victor plate reader and the position 
of the virus by a TCID50 assay. Liposomes with 1 mol % fluorescent NBD-PC were 
decorated with receptor and virus, exactly like for RT-PCR, and mixed with 67% w/v 
sucrose in TrisNaCl buffer to give a 50% w/v sucrose solution which was overlaid with 25 
and 0% w/v sucrose solutions. Centrifugation at 45000 rpm moved liposomes to their 
corresponding sucrose density whereas virus particles stayed at the high density bottom of 
the gradient. Fractions were taken from the top to the bottom and their lipid content was 
determined based on the fluorescent lipid NBD-PC (see Figure 4-17).  
 
Figure 4-17. Liposomes in of sucrose gradient fractions after flotation. Plain nanocontainers or 
nanocontainers decorated with only a few virus particles both flotate at the top of the 25% 
sucrose step (fraction 6), whereas a high virus concentration causes a shift to the bottom of the 
same step (fraction 8). Fluorescence of NBD-PC was determined in a Victor plate reader 
(Wallac). 
 
Plain nanocontainers (NC) were mainly found in fraction 6, just as nanocontainers which 
had not been decorated with receptor and then mixed with native virus particles, 135S or 
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80S. Receptor decorated nanocontainers with 91 fmol virus / 64 noml lipid had a similar 
flotation pattern, their corresponding peak was just a bit broader. This was caused by a 
slight distribution of the liposomes depending on the amount of virus bound to each 
nanocontainer.  The peak-shifting effect of virus bound to the membrane became 
especially obvious with a sample consisting of receptor decorated nanocontainers and 10 
times more virus. Due to the contribution of the high number of virus particles bound to 
the liposomes, the complex was shifted to fraction 8. 
Unbound virus had been separated from the liposomes and only receptor-coupled virus 
co-flotated, which was shown by a TCID50 assay of aliquots of all fractions of a sample with 
receptor and one without receptor (depicted in Figure 4-18). Without a receptor, most of 
the virus accumulated at the bottom of the gradient, whereas receptor bound to the 
liposomes caused a shift of the virus to the same fractions which also contained liposomes. 
 
Figure 4-18. TCID50 of fractions of the sucrose step gradient after flotation of a sample 
consisting of nanocontainers decorated with receptor and virus (NC+R+V) and another sample 
of just nanocontainers and virus (NC+V). The receptor binds the virus to the nanocontainers 
which causes more than 90% of infectious virus to flotate in fraction 7, whereas unbound virus 
remains at the bottom of the gradient in fraction 12. The bound virus gives rise to a signal for 
RNA transfer, which cannot be seen in a flotated sample without receptor (see Figure 4-21). 
From pictures of the liposome-receptor-virus complexes taken by electron microscopy, it 
was possible to count virus particles per liposome and compare that actual number with 
calculated ratios. On the pictures (Figure 4-19 A, flotated standard nanocontainer system 
sample) not all virus particles are still bound to the liposomes, nevertheless they must 
have adhered during flotation, otherwise it would not be possible to find them in the same 
fraction as the liposomes in the upper 25% sucrose area (picture of a sample without 
receptor is not shown because only plain liposomes can be seen, comparably to Figure 
4-10; the virus alone flotates at the bottom of the gradient in the high density sucrose, 
shown by the TCID50 assay). 
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Figure 4-19. TEM pictures of a standard nanocontainer system sample with 91 fmol virus / 64 
nmol lipid (A) and with 10x HRV2 (B) after flotation, taken at 56k magnification. In average, 3 
virus particles are bound to each liposome in the standard sample, 10 times more virus causes 
aggregation of the liposomes. Size bar = 200 nm. 
It was found that the calculation of about 3 virus particles per liposome in the case of 91 
fmol virus / 64 nmol lipid had been quite accurate and could be trusted to really reflect the 
situation in liposome decoration for RT-PCR. A shift of the fraction containing the 
liposomes can be reached by applying a very high virus concentration. When binding 
around 30 virus particles per liposome (see Figure 4-19 B), the density increased and 
forced the liposomes to flotate close to the interface between 25% and 50% sucrose. The 
highly concentrated virus also crosslinked the liposomes to form big aggregates. This 
caused the liposomes to contract to a small area, reflected by the high and sharp peak in 
fluorescence measurement. Aggregation can also be seen on pictures taken with the 
microscope.  
Most 135S particles, converted prior to their addition to the nanocontainers, could not 
bind to the liposomal membrane and were not found in the same fraction as the 
nanocontainers after flotation (see Figure 4-20, A). Addition of 80S had a similar 
outcome, since the fully converted particles have no hydrophobic residues for membrane 
attachment externalized, no particle co-flotated with the liposomes (see Figure 4-20, B). 
Conversion to 135S in the presence of the liposomal membranes was not possible because 
addition of liposomes to the virus would cause dilution of the viral sample. As already 
described by Weiss [41], conversion of a diluted virus sample results in 80S instead of a 
halt at the 135S intermediate. Only conversion in the presence of membranes is expected 
to result in several viral particles adhering to the membrane via the externalized VP4 and 
VP1 N-terminus. Once these peptides are lost, the particle is not able to anchor itself to the 
membrane anymore. 
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Figure 4-20. TEM pictures of nanocontainers with 135S (A) and 80S (B) after flotation. 135S 
were produced prior to their addition to the liposomes and did not adhere tightly enough to co-
flotate with them, only very few were found on the liposomal membrane. Preformed 80S did 
not bind to the liposomal membrane. Magnification 56k; size bar = 200 nm. 
Together with the results from virus-decorated samples (Figure 4-19) this indicates the 
necessity of a receptor for tight binding of the virus to the liposomal membrane, unbound 
native virus or subviral particles do not adhere by themselves.  
To make sure that the tightly bound virus alone is enough to give a detectable signal for 
RNA transfer in RT-PCR and the additional free virus from normal RT-PCR is not needed, 
liposome containing fractions were combined after flotation, bound virus was triggered by 
pH 5.4 and the RT reaction was performed. Transcribed cDNA was precipitated with 
ethanol and 3 M NaAc using glycogen as a carrier and amplified by PCR (for result see 
Figure 4-21). It could be shown that 3 virus particles per liposome are enough to give a 
positive signal for RNA transfer (lane 1). If no receptor was present to mediate the tight 
attachment of virus to the liposomal membrane during flotation in the sucrose step 
gradient, the virus was separated from the liposomes and therefore could not give rise to a 
signal for RNA transfer (lane 2). The band has the same size and intensity as the 
background signal determined by RT-PCR of flotated plain liposomes (lane 4). Reduction 
of the virus concentration by a factor 5 reduced the amount of transferred RNA below the 
detection limit (lane 3). 
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The flotation of receptor and virus decorated liposomes at typical nanocontainer system 
ratios removed all broken virus particles which were not able to bind the receptor. 
Electron microscopy of such a sample depicted the complexes and the effect of 15 min 
acidification (see  Figure 4-22), which turned part of the native virions into 80S particles. 
 
In summary, by flotation experiments it was possible to determine if viral and subviral 
particles were able to adhere to the liposomal membrane by themselves or if they needed a 
mediating receptor to do so. Decoration of the nanocontainers with MBP-V33333-His6 
resulted in co-flotation of liposomes and native virus. The fraction containing the complex 
depended on the virus concentration: large amounts of applied virus contributed to a 
higher overall density of the sample, shifting the complex to a higher density fraction, 
close to where free virions were found. A high virus concentration, i.e. more than about 
Figure 4-21. RT-PCR of flotated 
nanocontainer system samples. RNA 
release was triggered after flotation, 
the cDNA transcribed in RT was 
precipitated and subjected to PCR. 
Only the standard sample with NC 
(64 nmol) + 36 pmol receptor + 91 
fmol virus (lane 1) was able to give a 
signal, when the receptor did not 
bind the virus to the liposomes (2) 
or the virus concentration was only 
1/5 (3), there was no signal. 
Background is given by the plain 
liposomes in lane 4. 
 
 Figure 4-22. TEM picture 
of a flotated and acidified 
standard nanocontainer 
sample (64 nmol lipid, 36 
pmol receptor and 91 fmol 
virus) at a 56k 
magnification. Many virus 
particles were converted 
to 80S particles. Size bar = 
200 nm. 
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0.6 pmol virus / 64 nmol lipids, also crosslinked the receptor-decorated liposomal 
membranes, forming large aggregates. If fewer virus particles were applied, they attached 
to the receptor-decorated liposomes but contributed too little density to significantly 
change the location of the liposomes in the sucrose density gradient in comparison to 
plain, non-decorated liposomes. Nevertheless, these virions were able to give an RT-PCR 
signal showing RNA transfer when triggered after flotation. Subviral particles which were 
converted prior to their addition to the membranes were not able to adhere. 
 
virus per liposome:  in vivo relevance:  
The nanocontainer system only yields results relevant to in vivo infection if the amount of 
infecting virus per liposome is comparable to the amount of virus infecting a cell in vivo. 
Therefore, the amount of liposomes and virus in one sample preparation was calculated, 
as to deduce the number of viruses per liposomes. Liposome number was calculated from 
the known amount of used lipids and their surface, in combination with the inner and 
outer surface of a sphere of 400 nm diameter. A typical sample containing 91 fmol virus 
and 35 fmol liposomes would add up to 2.6 virus particles per liposome. 
The 91 fmol virus corresponded to 108 median tissue culture infective doses (TCID50), 
which are distributed all over the total outer liposomal surface. Assuming a typical cell has 
a diameter of 40 µm, applying the same TCID50/surface ratio would give around 50 
TCID50 per cell. This is in a range comparable to the infective doses used for cell infection 
in tissue culture, which are normally around 10 TCID50 per cell. 
 
RNA quantification via quantitative PCR: 
RNA transferred into liposomes was transcribed into cDNA via the encapsulated RT kit. 
The low amount of cDNA could not be seen on an agarose gel, therefore it was amplified in 
a PCR reaction prior to application on an agarose gel. This was mainly a semi-quantitative 
method, either there was a band visible or not. Quantification of the band intensity via 
ImageJ allowed the comparison of RNA transfer efficiencies, but it was not possible to 
determine the exact number of transferred RNA copies. A method to directly quantify how 
many viral genomes had entered the liposomes would be desireable. Quantitative PCR is 
an established method of quantification of starting material.  
The reaction mix was composed of Taq DNA Polymerase Master Mix RED, Fluorescein 
additive, SYBR Gold dye, template DNA and primers which had been designed to 
recognize all serotypes of HRV [31] (see primer index). Their specificity for all HRVs was 
rendered possible by targeting a highly preserved region in the viral 5’ UTR region with 
sequences obtained from 100 recognized HRV prototype strains additionally to field 
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isolates. The qPCR machine chosen to work with here was a BioRad iCycler, after also 
testing the Eppendorf Realplex Mastercycler and the Roche Lightcycler. 
By selecting the primers, the assay can either be optimized for HRV2 or for all HRV 
serotypes when employing the general primers developed by Lu et al. [31]. The choice of 
how to produce the standard curve is crucial to gain the desired information about 
transcribed cDNA amount. At first whole virus particles were employed, they were used 
for serial dilutions and their released RNA was subjected to RT and qPCR. Calculating 
from the threshold cycle (Tc) values of samples back to their RNA content with the help of 
this virion standard curve could not give exact starting values, since this would only be 
possible if the number of virus particles was the same as free RNA molecules. This 
assumption might not be met; the virus preparations contain a large amount of inactive 
virus particles which do not release their RNA for cDNA synthesis and subsequent qPCR 
detection. As a result, in vitro synthesized HRV2 RNA of a known size, spanning the qPCR 
amplicon, for an RNA based standard curve would be a better choice. It would allow the 
determination of the absolute number of RNA strands transcribed into cDNA. For that 
purpose it was necessary to obtain RNA of exactly one size, spanning the region which was 
amplified during qPCR, otherwise it was not possible to calculate the RNA copies from 
total RNA concentration measured by NanoDrop. Unfortunately, the attempts made here 
proved to be unsuccessful. When applying the in vitro transcribed RNA to an agarose gel it 
was visible that most of the RNA was of the intended size, but some was of smaller or of 
bigger size (data not shown), tampering with the RNA copy number calculation. The big 
problem of RNA, fast digestion, made it difficult to synthesize RNA of one distinct size 
which is the prerequisite for molecule copy number calculation. During the course of these 
experiments, the overall qPCR sensitivity decreased (shown in Figure 4-23) due to an 
unidentified factor. Before further advancing the RNA based standard curve, the overall 
sensitivity has to be increased again. 
Although it was aimed at increasing the sensitivity of the assay, in fact it decreased with 
time. Figure 4-23 depicts several dilution series of HRV2 performed over several months 
(time-lag indicated).  
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Figure 4-23. Standard curves for qPCR produced over several months from dilution series of 
HRV2. Curves created within the first 2 months are indicated in black, later ones in grey. The 
dark grey graph was measured on an Eppendorf Mastercycler in contrast to all other samples, 
which were run on a BioRad iCycler. 
Highest sensitivity equals to lowest threshold cycle number (Tc) at a given HRV2 
concentration. Since the amount of cDNA transcribed in nanocontainers was low, the 
decreasing sensitivity of the qPCR did not allow the quantification of these samples.  
The reason for the loss of sensitivity could not be found. Aging and therefore dysfunction 
of certain qPCR mix compounds seemed probable since the loss was time dependent, 
although it could not be solved by using fresh DNA polymerase master mix, SYBR Gold or 
Fluorescein additive. Only primers could not be replaced, but since the same primers were 
used successfully in standard PCR it is unlikely that they are the responsible component. 
Amplification products of the qPCR could be applied to agarose gels to check if the 
amplification itself worked. Low template amounts did not yield a visible product (data 
not shown), just as detected by qPCR fluorescence measurement. Hence it was the 
sensitivity of the amplification that failed and not the in parallel running detection of 
activated SYBR Gold. It was not possible to solve that problem in time. 
 
inhibition of RNA transfer: 
Several drugs have been used previously in cell culture to inhibit viral infection [45]. 
Testing their blocking capacity in the nanocontainer system would be a faster and easier 
way to test a drug’s influence on RNA transfer. Experiments to determine their mode of 
action could be done. Also it is a chance to test the usefulness of the nanocontainer system. 
Amiloride and its derivatives hexamethylenamiloride (HMA), 5-(N-ethyl-N-
isopropyl)amiloride (EIPA) and rimantadine were checked for their RNA transfer 
inhibiting capacity employing the nanocontainer system. First, each drug was added 
during liposome decoration between receptor and virus addition and RT-PCR was 
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performed. The cDNA transcription was totally inhibited in the sample containing 5 mM 
Amiloride and to a high extent in the sample containing 0.1 mM HMA, whereas EIPA and 
rimantadine did not exhibit any inhibitory effect (see Figure 4-24 for results). Separate 
reverse transcription reactions, which were not encapsulated in liposomes, supplemented 
with the drugs showed that the drugs did not interfere with the RT reaction. Virus 
triggered to release its RNA first was added to the RT mix together with the released RNA. 
The transcription of cDNA showed that the drugs had no inhibitory effect on the RT 
reaction itself (data not shown). Also virus added in its native form to the sample and 
triggered by pH lowering in situ led to cDNA transcription. Unfortunately, this cannot be 
handled as a prove that the drugs did not stop the RNA release from the virus, because it 
was also detected that the virus prep contains not only closed native virus particles but 
also enough free RNA to give a strong RT-PCR signal even without triggering the RNA 
release. 
 
Figure 4-24. RT-PCR of nanocontainer system samples treated with antiviral drugs or other 
chemical compounds which are supposed to have some influence on viral infectivity. The low 
signal of the standard sample with 91 fmol virus (lane 2) compared to the sample with 10 fold 
higher amount of virus (1) is due to the use of a low-infectious virus preparation. All other 
samples were prepared with the standard amount of virus. Standard sample on lane 2 had 
been treated with different drugs (lanes 3-6). A standard sample without any receptor is shown 
on lane 7, which had been treated with calcium (8) and a calcium chelator to remove all 
available calcium from the reaction (9). Positive control of an unpurified standard sample on 
lane 10 and a RT control on lane 11. 
 
effect of calcium and EGTA on RNA transfer: 
Calcium is bound to the dome at the fivefold axis of the viral capsid and is supposed to 
play a role in virion stability and uncoating. It is present to some extent in the receptor 
decorated liposome samples because the receptor storage buffer contains 10 mM CaCl2, 
which is needed by the receptor for correct folding. The addition of 1 µl receptor to a 20 µl 
total volume sample therefore results in the presence of about 0.5 mM CaCl2. To test if the 
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presence of calcium in the sample would increase the RNA transfer efficiency even without 
any receptor present, CaCl2 was added to 1 mM end concentration in the sample before 
virus was added. Then, the RT-PCR was performed as usual and the signal intensity was 
compared to a sample without supplemented calcium (see Figure 4-24, lanes 7 to 9). The 
signal intensified visibly, clearly stating the RNA transfer supporting role of calcium. Then 
again it might not be an essential part of RNA transfer and could be omitted without total 
loss of transfer. This was tested with ethylene glycol tetraacetic acid (EGTA), a calcium-
chelating agent which was added to 1 mM end concentration to plain liposomes before 
virus addition. This sample gave no sign of cDNA production, stating the necessity of ions 
for the RNA transfer. Calcium may be present in standard samples from receptor buffer 
and the virus preparation, when the virus imports the ion itself from replication in its host 
cell. Another ion, which was added as part of the reverse transcription buffer and is also 
chelated to some extent by EGTA, was magnesium (5x first strand buffer (Invitrogen) 
contains 15 mM MgCl2). Since EGTA had an effect on samples containing hardly any 
calcium, it might be conceivable that magnesium could have the same function as calcium 
in samples lacking an appropriate amount of the latter ion. 
RNA transfer of HRV through model membranes 
Discussion 
- 70 -  diploma thesis by Nena M. Matscheko 
 
5 Discussion 
Liposomes as a simple model membrane system for viral infection of host cells have 
been further evolved into a nanocontainer system where liposomes are filled with an RT 
mixture and decorated with a recombinant receptor for HRV2 to permit virus attachment 
and RNA transfer into the nanocontainer upon a trigger. It can not only be used for taking 
a look at virus attachment from the outside but also for RNA transfer studies, detecting 
the viral RNA inside the liposomes via RT-PCR. In the current thesis, weaknesses of the 
system like variability were addressed and, after solving that, the system was characterized 
and put into use. The nanocontainer system had only been developed for minor group 
Human Rhinovirus. Limitations are the chosen minor group receptor which is derived 
from a member of the LDLR family, and the specific primer used for RT. To expand the 
research applications of the nanocontainer system, a recombinant receptor derived from 
the major group HRV receptor, ICAM-1, was engineered in the course of this diploma 
thesis.  
5.1 Elimination of reactions potentially disturbing the 
nanocontainer system.     
At the beginning, nanocontainers were produced according to the protocol of Gerhard 
Bilek [29]. Liposomal membranes were made of POPC, PE, SM, Ch, Ni-DGS-NTA and 
NBD-PC in a molar ratio of 1 : 1 : 1 : 1.5 : 0.5 : 0.05, the hydration buffer, which was 
encapsulated by the liposomes, consisted of a complete reverse transcription mix, i.e. 
enzyme specific buffer, dNTP mix, reverse primer, DTT, RNase inhibitor and reverse 
transcriptase. Already Bilek had experienced difficulties with the reproducibility of the 
system. It appeared that although the liposomes looked spheric in pictures taken with the 
electron microscope and the RT mixture worked properly outside of the liposomes, there 
was hardly any signal detectable in RT-PCR from the inside of nanocontainers. It was not 
known if the failure was due to a problem inside or outside of the nanocontainers, it might 
have concerned every step of the virus-receptor interaction, the receptor-liposomal 
membrane attachment, the RNA transfer, the reverse transcription or the PCR. Many of 
the reagents were replaced by fresh or different preparations, for example the V33333 
receptor was substituted by V123, another recombinant receptor derived of the VLDLR, 
and a fresh preparation of V33333. The new receptor preparation of V33333 only 
contained 5.8 µM imidazole in the receptor buffer, whereas the previous preparation had 
an imidazole content of 10 mM. The reduction of this competitor for Ni2+ might increase 
the binding capacity of the receptor since fewer Ni-DGS-NTAs are blocked by imidazole.  A 
change in the hydration buffer composition to 10x more primer temporarily resulted in 
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increased signal intensity, but this was not confirmed in following experiments. Editing of 
the established RT-PCR program to give the RT reaction more time neither enhanced the 
signal. A breakthrough was finally made by the alteration of the lipid composition. The 
fluorescent lipid NBD-PC, although incorporated only in traces compared to the rest of the 
lipids, gave the membranes a distinct yellow tint. Without this lipid, the preparation 
should have been transparent to white. When omitting NBD-PC in the liposomal 
membrane preparation, still a strong color change to rubiginose was noticed upon 
addition of the hydration buffer. It was found that the Ni2+ bound to DGS-NTA reacted 
with DTT at the pH present in the RT mixture. DTT consists of two sulfhydryl groups 
attached to a four carbon threitol. It has a low redox potential of -0,33 V at a pH of 7 which 
enables the chemical to keep reduced SH groups unbound and quantitatively reduce 
present disulfide bridges, oxidizing itself in the process to circularize via an intramolecular 
disulfide bridge. The Ni-DGS-NTA is a crucial part of the nanocontainer system, as it 
mediates the attachment of the receptor and therefore virus to the liposomal membrane. 
Without the active Ni2+, the receptor is not able to interact via its His6-tag. Since later 
experiments showed that RNA transfer can also happen without receptor in a 
concentrated sample, the complexation of Ni2+ by DTT probably caused complete 
shielding of the liposomal surface from the interacting virus. DTT is normally added to an 
RT reaction to protect the enzyme from oxidation following contact with ambient oxygen 
and to inactivate RNases via reducing their disulfide bridges. Omitting DTT in the RT 
mixture in order to prevent a reaction with Ni2+ resulted in functional nanocontainers. 
RNases were still inhibited with RNasin (Promega), a commercial RNase inhibitor. The 
oxidation and hence the accelerated aging of the encapsulated enzyme was probably 
limited inside the membranes or had to be accepted as a trade off.  
5.2 Generalizing the nanocontainer system for all HRV 
serotypes.  
The viral infection model system of nanocontainers has been improved and 
characterized. First, composition and procedure of the standard RT-PCR reaction 
provided by Bilek were optimized. In the beginning, a primer set giving an amplicon on 
the 3’ end of HRV2 and one producing an amplicon on the 5’ end of HRV2 were used. 
Although they generated distinct amplicons for HRV2, they were abandoned in favor of 
generally applicable primers for all HRV serotypes. This was a step towards broadening 
the nanocontainer model system for research on all HRV species. The newly introduced 
primers had been described by Lu et al. [31] and were intended for use in RT-PCR as well 
as quantitative PCR. Their product was a short amplicon of 204 nt on the border of the 5’ 
UTR of the HRV genomic RNA. The reverse primer was designed in a way that it would 
RNA transfer of HRV through model membranes 
Discussion 
- 72 -  diploma thesis by Nena M. Matscheko 
 
bind to a region highly conserved among all HRV and human enteroviruses (HEVs). In 
contrast, the forward primer was designed to be complementary to a variable region that 
contained a signature T indel in HEVs but not HRVs, allowing its exploitation for 
differential amplification. Locked nucleic acid analogues (LNA) that increase 
thermodynamic stability were introduced into the short forward primers to raise their 
melting temperature comparably to that of the longer reverse primer. These primers 
worked best at an annealing temperature of 60°C although the calculated melting 
temperature was considerably lower for the reverse primer (see primer index attached). 
The second HRV serotype dependent component of the nanocontainer system was the 
receptor. Only 12 HRV serotypes use the minor receptor, the larger part employs ICAM-1 
for internalization. For investigation of the RNA transfer of HRV2, a member of the minor 
group, a soluble recombinant VLDLR had already been developed by Ronacher et al. [46]. 
RNA transfer of major group viruses is believed to follow a different pathway. The 
attachment of virus to ICAM-1 induces structural changes for which the minor group virus 
needs the additional trigger of acidification [18, 47]. Controlling the moment of uncoating 
in the nanocontainer system, like it is done via acidification of minor group viruses, could 
be impossible with major group viruses. For detection of transferred viral RNA by RT in 
the lumen of the nanocontainers it is mandatory to keep the liposomal membrane intact. 
This was no problem with minor group viruses, whose viral capsids have been detected in 
lysosomes after releasing their RNA into the cytosol [48] and endosomal pH was 
unaffected by successful HRV2 infection [49], pointing at the formation of a pore without 
disrupting the membrane. Major group viruses seem to disrupt the endosomal membrane 
and reach the cytosol with the RNA as well as with the capsid [50-51]. Disruption of the 
nanocontainer membrane would render any RNA detection impossible. Although further 
studies employing the nanocontainer system would not be possible with the major group 
virus if this was really the case, it would be interesting to find out if major group viruses 
disrupt the membrane upon attachment to ICAM-1, if they need the low pH as additional 
trigger to do so or if they can also form a pore for RNA transfer across the membrane. A 
recombinant ICAM-1 receptor was cloned in the course of the present work which can be 
expressed in eukaryotic cells for the addition of glycosidic chains which increase the 
solubility. The implementation of this receptor extends the nanocontainer system to the 
use of major group viruses. 
5.3 Determining the ideal sample composition.  
Leakage experiments performed by Weiss et al. [52] on liposomes and different HRV 
concentrations have shown that a virus concentration above a certain threshold in relation 
to the used lipid causes leakage of the liposomes, losing its encapsulated fluid to the 
exterior. If the interior and exterior of the liposomes are different, like it is the case in the 
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nanocontainer system where an RT mix fills the inside of liposomes which are surrounded 
by iso-osmotic buffer, the mixture of the two fluids results in a dilution of both. Since 
diluted RT mix is not able to transcribe RNA into cDNA anymore, the leakage of 
nanocontainers causes a decrease or total loss of the signal intensity. This causes a trade 
off, because enough virus has to be applied to the nanocontainers to reach a detectable 
cDNA template concentration for PCR, but not so much as to cause leakage. A serial 
dilution of HRV2 with constant amounts of nanocontainers and receptor reflected these 
two counteracting influences on the signal intensity (see Figure 5-1).  
 
Figure 5-1. RT-PCR of a virus dilution series in the nanocontainer system (grey) with leakage in 
the same virus/lipid ratio range indicated (black). Leakage data according to Weiss et al. [52], 
RT-PCR signal from agarose gel bands quantified with ImageJ. Highest RT-PCR signal 
corresponds to the highest virus concentration with 0% leakage (-5.8 log virus/lipid ratio, 
equivalent to 108 TCID50 or 91 fmol virus /64 nmol lipid). 
Upon use of high virus concentration that is supposed to cause 100% of the 
nanocontainers to leak, the signal obtained from RT-PCR equals zero, because all viral 
RNA that had been transferred across a liposomal membrane was exposed to a diluted RT 
mix, which was not able to produce any detectable cDNA. Lowering the HRV2 
concentration by half to a range where about 60% of the nanocontainers stay intact, 
results in a clearly detectable signal in RT-PCR. The signal intensity can be potentiated by 
decreasing the applied virus to the point where leakage of the nanocontainers can be 
neglected. The exact virus/lipid ratio at the crossing point to 0% leakage will give the 
strongest signal because all RNA that reaches the liposomal lumen is transcribed into 
cDNA. Decreasing the virus concentration further only results in less transferred RNA and 
therefore reduced signal intensity as is indicated by the declining signal in Figure 5-1. The 
ideal virus/lipid ratio to yield the strongest signal for RNA transfer was calculated to be 
around 3.4 x 10-6 from the data provided by Weiss et al., the ratio for the strongest signal 
in the nanocontainers was 1.4 x 10-6, i.e. in a similar range, although a little less dilution of 
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the virus would still be possible without risking leakage. Summarized, the ideal virus – 
receptor – lipid concentrations are about 90 fmol virus, 36 pmol receptor and 64 nmol 
lipid (1: 400 : 711111 molar ratio) in one sample preparation.  
The RT efficacy-reducing effect of leakage also supports the hypothesis of pore 
formation for RNA transfer through the lipid bilayer as the first option for transferring the 
viral RNA to the cellular cytoplasm. The second possibility, total disruption of the 
membrane by the virus for RNA transfer, would cause 100% leakage of all nanocontainers, 
resulting in no cDNA transcription at all. Since RT-PCR signals are only produced at a 
virus concentration below a certain threshold of leakage, the RNA must enter the 
nanocontainer via a small pore which does not allow any leakage. If many virions bind 
along the membrane next to each other and each of them starts to fold the membrane 
around them, the lipid bilayer will be strongly disturbed and finally disrupted, causing 
leakage.  
5.4 Ratio total particles to infectious particles.  
A virus preparation from cell culture [12], as employed in these experiments, contains 
varying shares of inactive virus particles. Numbers for virus concentration in mg/ml 
determined via CE [53] are only little helpful related to their use in infectious assays. The 
problem is not that parts of the detected virions are non-infectious, but that this part is 
varying in each new preparation, maybe even in each aliquot. As long as it would remain 
at a comparable levels the same correction factor could be applied to all preparations and 
therefore would not be noticed. Unfortunately, sometimes there are very bad preparations 
with substantially high proportions of inactive virus which give low signals in infection 
assays when standard virus amount measured in [grams] were used. Several virus 
preparations used in these experiments are presented below, their concentration in mg/ml 
determined via CE, their infectivity in TCID50/ml and the resultant virus particles / TCID50 
ratios are indicated.  
 
 TCID50/ml mg/ml virus particles / TCID50 
1. 1.00 x 1012 7.3 543 
2. 3.16 x 1011 18.0 4235 
3. 2.31 x 1011 5.8 1867 
4. 5.62 x 1011 8.1 1072 
 
This ratio has already been determined for other viruses, for example it is 30-1000 virus 
particles / PFU in poliovirus [5] and 10-100 virus particles / TCID50 in adenovirus 
preparations [54], although it has to be noted that the virus particle number was 
determined via counting virions in microscopy and not by determining total protein via CE 
like it was done here. Although our preparations are in a similar range (1 PFU equals 10 
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TCID50), the great variance in our HRV2 preparations (between 540 and 4240) makes it 
important to express and compare the amount of virus used in an infection assay also in 
TCID50 units and consider the quality of the specific preparation. Calculated 2.6 virus 
particles per liposome as are employed in standard nanocontainer samples could equal to 
TCID50 per liposome values between 1.5 and 4.7 x 10-3. 
5.5 The influence of drugs and calcium on RNA transfer, 
determined by the nanocontainer system.  
Many HRV infection influencing actions take place inside the endosomes within the 
cell. The nanocontainer system makes them easier accessible for study. The drug 
ethylisopropylamiloride (EIPA; an amiloride-derived analogue) has been shown to inhibit 
HRV14 infection of human tracheal epithelial cells at a concentration of 10 µM [55]. The 
drug amiloride was used successfully at 5 mM final concentration for the inhibition of 
HRV2 and HRV14 infection of RD-ICAM cells in cell culture [45].  In the present work, 
both drugs were tested together with other antivirals, hexamethyleneamiloride (HMA) 
and adamantylethanamine (rimantadine), for their anti-infective capacity in the 
nanocontainer system. Surprisingly, only amiloride prevented the signal, whereas EIPA 
was not even effective at a concentration of 1 mM, which is 100x more than the 
concentration successfully employed in cell culture. This could be explained by the 
different modes of action of both drugs. EIPA was suggested to inhibit infection by 
preventing the endosomal acidification [55]. Since acidification of the nanocontainer 
system is done from the outside and cannot be influenced by EIPA, it is without effect in 
this artificial system. The discussed effects of amiloride are diverse and include the 
inhibition of RNA release into the cytosol. The mode of action of this inhibition is not 
clear. Running liposomes treated with amiloride in CE pointed to a membrane disrupting 
effect (unpublished data). In vivo this would prevent the acidification of the endosome 
and therefore the RNA release. Disruption of the liposomal membrane in the 
nanocontainer system would also cause leakage and therefore dilution of the RT mix, 
rendering the detection of released RNA impossible.  
The RT reaction itself has been found to be left undisturbed by all drugs, but RT-PCR of 
the nanocontainer system has always to be done in combination with leakage experiments 
in CE to rule out the possibility of detection failure due to dilution of the RT mix. It was 
impossible to test the direct influence of the drugs on viral uncoating. A non-encapsulated 
RT mix always gives a signal from free RNA present in every virus preparations. Even if 
uncoating was inhibited by the drugs, there would still be a signal from free RNA. HMA 
diminished the signal for RNA transfer but could not totally erase it, rimantadine proved 
to be ineffective. 
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It has already been found before that the divalent ion calcium plays an important role 
in the structure and function of many viruses. Li et al. [56] suggested the implication of 
calcium in virion assembly, cell attachment and entry and the nucleus entry of simian 
virus 40 (SV40). Also in icosahedral plant viruses, whose structure resembles rhinoviral 
capsid structure, implication of calcium in the uncoating process has been shown 
previously [57-58]. Amino acids that normally bind Ca2 + in Cowpea chlorotic mottle virus 
(CCMV) and Tomato bushy stunt virus (TBSV) release the ion via charge repulsion caused 
by an acidic pH. The resulting conformational changes create a 20 Å wide channel at the 
quasi three-fold axes by expansion of the whole capsid, a process that is similar to 
conformational changes observed in HRV for RNA release [18]. 
Although also a zinc ion is under discussion [59], HRV14 and HRV16 most probably 
contain a calcium ion on the icosahedral fivefold axis, which plays a role in viral uncoating 
upon acidification in the endosome [3]. Addition of CaCl2 to the nanocontainer system 
lacking the receptor increased the RNA transfer significantly compared to the same 
sample without CaCl2. Furthermore it was possible to reduce the RT-PCR signal strongly 
by the addition of the calcium-chelator EGTA prior to virus challenge of plain 
nanocontainers. Also RNA transfer through receptor decorated nanocontainers was 
boosted by CaCl2. The LDLR is known to need calcium to maintain its correct folding, but 
the above described RNA transfer experiment with nanocontainers not decorated with any 
receptor points at a function of calcium directly related to the virus. After stabilizing the 
viral capsid in its native form, the dissociation of the ion due to acidification might favor 
the transition of the viral capsid to its hydrophobic intermediate state (135S particle) in 
which it can attach to membranes without receptor and subsequently release its RNA into 
the cell or liposome, respectively.  
 
RNA transfer of HRV through model membranes 
  Conclusion 
diploma thesis by Nena M. Matscheko   - 77 - 
 
6 Conclusion 
Liposomes with a lipid composition close to endosomal membranes, decorated on their 
surface with a recombinant receptor derived from the minor group HRV receptor VLDLR, 
serve as a model system for RNA transfer of HRV2 across a membrane. The direct 
detection of transferred RNA in the lumen of the liposomes via an encapsulated RT mix 
(such liposomes are termed “nanocontainers”) was not reproducible at the beginning of 
the present diploma thesis. The reducing agent DTT, a component of the RT mix, was 
identified as the main cause. It reacted with the nickel complexed by the lipid DGS-NTA 
which mediates receptor attachment to the liposomal membrane via a His6-tag. The 
nanocontainer system was found to give the strongest signal with a molar ratio of virus : 
receptor : lipid of 1 : 400 : 711111, i.e. a virus/lipid ratio of 1.4 x 10-6. Higher virus 
concentrations induced leakage of the nanocontainers; consequentially, the diluted RT 
mix was not able to transcribe any cDNA. Lowering of the virus concentration resulted in 
proportionally weaker RT-PCR signals. Obviously, single HRV2 particles do not disrupt 
the membrane during RNA transfer but rather move it through a pore. Although RNA was 
transferred in a concentrated sample even without any receptor, it could be demonstrated 
via flotation experiments that the receptor is necessary to tightly bind the virus to the 
liposomal membrane. Once formed, 135S and 80S particles are not able to tightly attach to 
the membrane. 
The antiviral drug amiloride was found to inhibit signals obtained with RT-PCR from 
the nanocontainers, in contrast to EIPA and rimantadine and to some extent HMA. 
Further CE experiments point at a leakage inducing effect of amiloride. High calcium 
concentrations could be demonstrated to enhance the RNA transfer strongly even without 
receptor, whereas the calcium chelator EGTA counteracted and prevented any RT-PCR 
signal, underlining the influence of the ion on the capsid stability and therefore infection 
efficiency. 
For the purpose of making the nanocontainer system applicable to all HRV serotypes, 
the HRV2 specific primers for RT, PCR and qPCR were replaced by suitable general 
primers. Truncated ICAM-1 receptors consisting of the extracellular domains 1-2 and 1-5 
and a His6-tag were cloned for the expression in eukaryotic cells and in bacteria. They are 
necessary for studying major group HRV. 
The nanocontainer system can now be used for various experimental set ups with 
minor group HRVs, e.g. for studying the antiviral capacity and activity of different 
chemical compounds, or imaging the process of viral uncoating on endosomal membranes 
in cryo-EM. Expression of the cloned major group receptor will also allow the same 
studies with major group HRVs. 
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8 Appendices 
8.1 Abbreviations 
abbreviation explanation 
A  Ampere 
Amp Ampicillin 
BGE background electrolyte 
cDNA complementary DNA 
CE capillary electrophoresis 
Da  Dalton 
dNTP deoxyribonucleotide triphosphate 
DTT dithiothreitol 
His6 Hexa histidine 
HRV Human Rhinovirus 
ICAM-1 intercellular adhesion molecule 1 
ICTV  international committee on taxonomy of viruses 
IRES  internal ribosome entry site 
Kan Kanamycin 
LB luria broth 
LDLR low density lipoprotein receptor 
LRP LDLR related protein 
LUV large unilamellar vesicle 
MBP maltose binding protein 
MLV multilamellar vesicle 
MOI multiplicity of infection 
mSEC mini size exclusion chromatography 
NC nanocontainer 
NEB New England Biolabs 
nt  nucleotide 
ORF  open reading frame 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PFU plaque forming unit 
PTA  phosphotungstic acid 
RT reverse transcription 
TCID50 median tissue culture infective dose 
TEM transmission electron microscopy 
Tet Tetracyclin 
UTR  untranslated region 
VLDLR very low density lipoprotein receptor 
VP  viral protein 
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8.2 Primer index 
 
Primers were ordered at VBC Biotech, Vienna, Austria except for *, which was ordered at 
Exiqon, Vedbaek, Denmark. 
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8.3 Nucleotide sequences 
8.3.1 Human Rhinovirus 2 with primer positions indicated 
sequence source: EMBL X02316 
1 ttaaaactgg atccaggttg ttcccacctg gatttcccac agggagtggt actctgttat 
       61 tacggtaact ttgtacgcca gttttatctc ccttccccca tgtaacttag aagtttttca 
      121 caaagaccaa tagccggtaa tcagccagat tactgaaggt caagcacttc tgtttccccg 
>> PF HRV2 5end 
      181 gtcaatgttg atatgctcca acagggcaaa aacaactgcg atcgttaacc gcaaagcgcc 
      241 tacgcaaagc ttagtagcat ctttgaaatc gtttggctgg tcgatccgcc atttcccctg 
      301 gtagacctgg cagatgaggc tagaaatacc ccactggcga cagtgttcta gcctgcgtgg 
          >> PF HRV2gen LNA 
(348) 
      361 ctgcctgcac accctatggg tgtgaagcca aacaatggac aaggtgtgaa gagccccgtg 
      421 tgctcgcttt gagtcctccg gcccctgaat gtggctaacc ttaaccctgc agctagagca 
      481 cgtaacccaa tgtgtatcta gtcgtaatga gcaattgcgg gatgggacca actactttgg 
     PR HRV2gen(553)  
      541 gtgtccgtgt ttcacttttt cctttatatt tgcttatggt gacaatatat acaatatata 
      <<                 PR HRV2_5end  << 
      601 tattggcacc atgggtgcac aggtttcaag acaaaatgtt ggaactcact ccacgcaaaa 
      661 ctctgtatca aatgggtcta gtttaaatta ttttaacatc aattatttca aagatgctgc 
      721 ttcaaatggt gcatcaaaac tggaattcac acaagatcct agtaaattta ctgacccagt 
      781 taaggatgtt ttggaaaagg gaataccaac actacagtcc cccacagtgg aggcttgtgg 
 
... 841 - 5940 ... 
      
     5941 cttagatatt gacccaaaac ctattacact tgaggacagt gtctttggca ctgatggatt 
     6001 agaggctctt gatttgaaca ctagcgcagg atttccatat attgcaatgg gagttaaaaa 
     6061 gagagattta ataaacaaca agaccaagga tataagcaaa cttaaagaag caattgacaa 
     6121 atacggagtt gacttaccta tggtcacctt cttgaaagat gaactcagaa agcatgaaaa 
 >>  PF HRV2-7A 
     6181 ggtaattaaa ggtaaaacta gagttattga agctagtagt gtgaatgata ccctattatt 
     6241 tagaacaact tttggcaacc tcttttcaaa gttccacttg aatcctggaa ttgttactgg 
     6301 atcagcagtt ggatgtgatc cagaggtgtt ttggtcaaaa ataccagcaa tgttggatga 
 
... 6361 – 6780 ... 
 
     6781 tagcaatgtt acttttttaa aaagagggtt taagcaagat gagaagtata actttctaat 
     6841 acatccaact ttccctgaag atgaaatatt tgaatccatc agatggacaa agaaaccatc 
     6901 acaaatgcat gaacatgtgt tgtctctgtg tcacttaatg tggcacaatg gacgtgacgc 
     6961 atacaaaaaa tttgtggaga agatacgcag tgtaagcgct ggtcgtgcac tgtacatccc 
     7021 tccgtatgat ttgcttttgc atgagtggta tgaaaaattt taaagatata gaaatagtaa 
   PR HRV2_3end  << 
     7081 actgatagtt tattagtttt at 
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8.3.2 Sequence of pCDM8-ICAM1-D2 
 
format explanation 
tagtc vector pCDM8 
CCTA 
insert ICAM1-D2 (270-898) 
insert ICAM1-D5 (270-1759) 
TCTAGA XbaI restriction site 
TAA stop codon 
CAT His codon 
G mutation 
 
ggcgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccga
aggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagttaggccaccacttcaagaactctgtag
caccgcctacatacctcgctctgctaatcctgttaccagtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaag
acgatagttaccggataaggcgcagcggtcgggctgaacggggggttcgtgcacagagcccagcttggagcgaacgacctacac
cgaactgagatacctacagcgtgagcattgagaaagcgccacgcttcccgaagggagaaaggcggacaggtatccggtaagcgg
cagggtcggaacaggagagcgcacgagggagcttccagggggaaacgcctgctatctttatgatcctgtcgggtttcgccacctct
gacttgagcgtcgatttttgtgatgctcgtcaggggggcggagcctatggaaaaacgccagcaacgcaagctagcttctagctaga
aattgtaaacgttaatattttgttaaaattcgcgttaaatttttgttaaatcagctcattttttaaccaataggccgaaatcggcaaaatc
ccttataaatcaaaagaatagcccgagatagggttgagtgttgttccagtttggaacaagagtccactattaaagaacgtggactcc
aacgtcaaagggcgaaaaaccgtctatcagggcgatggccgcccactacgtgaaccatcacccaaatcaagttttttggggtcgag
gtgccgtaaagcactaaatcggaaccctaaagggagcccccgatttagagcttgacggggaaagccggcgaacgtggcgagaaa
ggaagggaagaaagcgaaaggagcgggcgctagggcgctggcaagtgtagcggtcacgctgcgcgtaaccaccacacccgccg
cgcttaatgcgccgctacagggcgcgtactatggttgctttgacgagaccgtataacgtgctttcctcgttggaatcagagcgggagc
taaacaggaggccgattaaagggattttagacaggaacggtacgccagctggattaccgcggtctttctcaacgtaacactttacag
cggcgcgtcatttgatatgatgcgccccgcttcccgataagggagcaggccagtaaaagcattacccgtggtggggttcccgagcg
gccaaagggagcagactctaaatctgccgtcatcgacttcgaaggttcgaatccttcccccaccaccatcactttcaaaagtccgaa
agaatctgctccctgcttgtgtgttggaggtcgctgagtagtgcgcgagtaaaatttaagctacaacaaggcaaggcttgaccgaca
attgcatgaagaatctgcttagggttaggcgttttgcgctgcttcgcgatgtacgggccagatatacgcgttgacattgattattgact
agttattaatagtaatcaattacggggtcattagttcatagcccatatatggagttccgcgttacataacttacggtaaatggcccgcc
tggctgaccgcccaacgacccccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagggactttccattgacgt
caatgggtggactatttacggtaaactgcccacttggcagtacatcaagtgtatcatatgccaagtacgccccctattgacgtcaatg
acggtaaatggcccgcctggcattatgcccagtacatgaccttatgggactttcctacttggcagtacatctacgtattagtcatcgct
attaccatggtgatgcggttttggcagtacatcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattg
acgtcaatgggagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcg
gtaggcgtgtacggtgggaggtctatataagcagagctctctggctaactagagaacccactgcttactggcttatcgaaattaatac
gactcactatagggagacccaagcttctagagatccctcgacctcgagatccattgtgctctaaAGTCGACGCTGAGCTC
CTCTGCTACTCAGAGTTGCAACCTCAGCCTCGCTATGGCTCCCAGCAGCCCCCGGCCCGC
GCTGCCCGCACTCCTGGTCCTGCTCGGGGCTCTGTTCCCAGGACCTGGCAATGCCCAGAC
ATCTGTGTCCCCCTCAAAAGTCATCCTGCCCCGGGGAGGCTCCGTGCTGGTGACATGCAG
CACCTCCTGTGACCAGCCCAAGTTGTTGGGCATAGAGACCCCGTTGCCTAAAAAGGAGTT
GCTCCTGCCTGGGAACAACCGGAAGGTGTATGAACTGAGCAATGTGCAAGAAGATAGCC
AACCAATGTGCTATTCAAACTGCCCTGATGGGCAGTCAACAGCTAAAACCTTCCTCACCG
TGTACTGGACTCCAGAACGGGTGGAACTGGCACCCCTCCCCTCTTGGCAGCCAGTGGGC
AAGAACCTTACCCTACGCTGCCAGGTGGAGGGTGGGGCACCCCGGGCCAACCTCACCGT
GGTGCTGCTCCGTGGGGAGAAGGAGCTGAAACGGGAGCCAGCTGTGGGGGAGCCCGCT
GAGGTCACGACCACGGTGCTGGTGAGGAGAGATCACCATGGAGCCAATTTCTCGTGCCG
CACTGAACTGGACCTGCGGCACCACCATCACCATCATTAATCTAGAggatctttgtgaaggaac
cttacttctgtggtgtgacataattggacaaactacctacagagatttaaagctctaaggtaaatataaaatttttaagtgtataatgt
gttaaactactgattctaattgttgtggtattttagattccaacctatggaacttatgaatgggagcagtggtggaatgcctttaatgag
gaaaacctgttttgctcagaagaaatgccatctagtgatgatgaggctactgctgactctcaacattctactcctccaaaaaagaag
agaaaggtagaagaccccaaggactttccttcagaattggtaagttttttgagtcatgctgtgtttagtaatagaactcttgcttgcttt
gctatttacaccacaaaggaaaaagctgcactgctatacaagaaaattatggaaaaatatttgatgtatagtgccttgactagagat
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cataatcagccataccacatttgtagaggttttacttgctttaaaaaacctcccacacctccccctgaacctgaaacataaaatgaat
gcaattgttgttgttaacttgtttattgcagcttataatggttacaaataaagcaatagcatcacaaatttcacaaataaagcatttttat
cactgcattctagttgtggtttgtccaaactcatcaatgtatcttatcatgtctggatcccgccatggtatcaacgccatatttctatttac
agtagggacctcttcgttgtgtaggtaccgctgtattcctagggaaatagtagaggcaccttgaactgtctgcatcagccatatagcc
cccgctgttcgacttacaaacacaggcacagtactgacaaacccatacacctcctctgaaatacccatagttgctagggctgtctccg
aactcattacaccctaccaagtgagagctgtaatttcgcgatcaagggcagcgagggcttctccagataaaatagcttctgccgaga
gtcccgtaagggtagacacttcagctaatccctcgatgaggtctactagaatagtcagtgcggctcccattttgaaaattcacttactt
gatcagcttcagaagatgggcgagggcctccaacacagtaattttcctcccgactcttaaaatagaaaatgtcaagtcagttaagga
ggaagtggactaactgacgcagctggccgtgcgacatcctcttttaattagttgctaggcaacgccctccagagggcgtgtggttttg
caagaggaagcaaaagcctctccacccaggcctagaatgtttccacccaatcattactatgacaacagctgttttttttagtattaag
cagaggccggggacccctgggcccgcttactctggagaaaaagaagagaggcattgtagaggcttccagaggcaacttgtcaaaa
caggactgcttctatttctgtcacactgtctggccctgtcacaaggtccagcacctccataccccctttaataagcagtttgggaacgg
gtgcgggtcttactccgcccatcccgcccctaactccgcccagttccgcccattctccgccccatggctgactaattttttttatttatgc
agaggccgaggccgcctcggcctctgagctattccagaagtagtgaggaggcttttttggaggcctaggcttttgcaaaaagctaat
tc 
 
8.3.3 Sequence of pCDM8-ICAM1-D5 
ggcgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccga
aggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagttaggccaccacttcaagaactctgtag
caccgcctacatacctcgctctgctaatcctgttaccagtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaag
acgatagttaccggataaggcgcagcggtcgggctgaacggggggttcgtgcacagagcccagcttggagcgaacgacctacac
cgaactgagatacctacagcgtgagcattgagaaagcgccacgcttcccgaagggagaaaggcggacaggtatccggtaagcgg
cagggtcggaacaggagagcgcacgagggagcttccagggggaaacgcctgctatctttatgatcctgtcgggtttcgccacctct
gacttgagcgtcgatttttgtgatgctcgtcaggggggcggagcctatggaaaaacgccagcaacgcaagctagcttctagctaga
aattgtaaacgttaatattttgttaaaattcgcgttaaatttttgttaaatcagctcattttttaaccaataggccgaaatcggcaaaatc
ccttataaatcaaaagaatagcccgagatagggttgagtgttgttccagtttggaacaagagtccactattaaagaacgtggactcc
aacgtcaaagggcgaaaaaccgtctatcagggcgatggccgcccactacgtgaaccatcacccaaatcaagttttttggggtcgag
gtgccgtaaagcactaaatcggaaccctaaagggagcccccgatttagagcttgacggggaaagccggcgaacgtggcgagaaa
ggaagggaagaaagcgaaaggagcgggcgctagggcgctggcaagtgtagcggtcacgctgcgcgtaaccaccacacccgccg
cgcttaatgcgccgctacagggcgcgtactatggttgctttgacgagaccgtataacgtgctttcctcgttggaatcagagcgggagc
taaacaggaggccgattaaagggattttagacaggaacggtacgccagctggattaccgcggtctttctcaacgtaacactttacag
cggcgcgtcatttgatatgatgcgccccgcttcccgataagggagcaggccagtaaaagcattacccgtggtggggttcccgagcg
gccaaagggagcagactctaaatctgccgtcatcgacttcgaaggttcgaatccttcccccaccaccatcactttcaaaagtccgaa
agaatctgctccctgcttgtgtgttggaggtcgctgagtagtgcgcgagtaaaatttaagctacaacaaggcaaggcttgaccgaca
attgcatgaagaatctgcttagggttaggcgttttgcgctgcttcgcgatgtacgggccagatatacgcgttgacattgattattgact
agttattaatagtaatcaattacggggtcattagttcatagcccatatatggagttccgcgttacataacttacggtaaatggcccgcc
tggctgaccgcccaacgacccccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagggactttccattgacgt
caatgggtggactatttacggtaaactgcccacttggcagtacatcaagtgtatcatatgccaagtacgccccctattgacgtcaatg
acggtaaatggcccgcctggcattatgcccagtacatgaccttatgggactttcctacttggcagtacatctacgtattagtcatcgct
attaccatggtgatgcggttttggcagtacatcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattg
acgtcaatgggagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcg
gtaggcgtgtacggtgggaggtctatataagcagagctctctggctaactagagaacccactgcttactggcttatcgaaattaatac
gactcactatagggagacccaagcttctagagatccctcgacctcgagatccattgtgctctaaAGTCGACGCTGAGCTC
CTCTGCTACTCAGAGTTGCAACCTCAGCCTCGCTATGGCTCCCAGCAGCCCCCGGCCCGC
GCTGCCCGCACTCCTGGTCCTGCTCGGGGCTCTGTTCCCAGGACCTGGCAATGCCCAGAC
ATCTGTGTCCCCCTCAAAAGTCATCCTGCCCCGGGGAGGCTCCGTGCTGGTGACATGCAG
CACCTCCTGTGACCAGCCCAAGTTGTTGGGCATAGAGACCCCGTTGCCTAAAAAGGAGTT
GCTCCTGCCTGGGAACAACCGGAAGGTGTATGAACTGAGCAATGTGCAAGAAGATAGCC
AACCAATGTGCTATTCAAACTGCCCTGATGGGCAGTCAACAGCTAAAACCTTCCTCACCG
TGTACTGGACTCCAGAACGGGTGGAACTGGCACCCCTCCCCTCTTGGCAGCCAGTGGGC
AAGAACCTTACCCTACGCTGCCAGGTGGAGGGTGGGGCACCCCGGGCCAACCTCACCGT
GGTGCTGCTCCGTGGGGAGAAGGAGCTGAAACGGGAGCCAGCTGTGGGGGAGCCCGCT
GAGGTCACGACCACGGTGCTGGTGAGGAGAGATCACCATGGAGCCAATTTCTCGTGCCG
CACTGAACTGGACCTGCGGCCCCAAGGGCTGGAGCTGTTTGAGAACACCTCGGCCCCCT
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ACCAGCTCCAGACCTTTGTCCTGCCAGCGACTCCCCCACAACTTGTCAGCCCCCGGGTCC
TAGAGGTGGACACGCAGGGGACCGTGGTCTGTTCCCTGGACGGGCTGTTCCCAGTCTCG
GAGGCCCAGGTCCACCTGGCACTGGGGGACCAGAGGTTGAACCCCACAGTCACCTATGG
CAACGACTCCTTCTCGGCCAAGGCCTCAGTCAGTGTGACCGCAGAGGACGAGGGCACCC
AGCGGCTGACGTGTGCAGTAATACTGGGGAACCAGAGCCAGGAGACACTGCAGACAGTG
ACCATCTACAGCTTTCCGGCGCCCAACGTGATTCTGACGAAGCCAGAGGTCTCAGAAGG
GACCGAGGTGACAGTGAAGTGTGAGGCCCACCCTAGAGCCAAGGTGACGCTGAATGGG
GTTCCAGCCCAGCCACTGGGCCCGAGGGCCCAGCTCCTGCTGAAGGCCACCCCAGAGGA
CAACGGGCGCAGCTTCTCCTGCTCTGCAACCCTGGAGGTGGCCGGCCAGCTTATACACA
AGAACCAGACCCGGGAGCTTCGTGTCCTGTATGGCCCCCGACTGGACGAGAGGGATTGT
CCGGGAAACTGGACGTGGCCAGAAAATTCCCAGCAGACTCCAATGTGCCAGGCTTGGGG
GAACCCATTGCCCGAGCTCAAGTGTCTAAAGGATGGCACTTTCCCACTGCCCATCGGGGA
ATCAGTGACTGTCACTCGAGATCTTGAGGGCACCTACCTCTGTCGGGCCAGGAGCACTCA
AGGGGAGGTCACCCGCGAGGTGACCGTGAATGTGCTCTCCCCCCGGTATGAGCACCAC
CATCACCATCATTAATCTAGAggatctttgtgaaggaaccttacttctgtggtgtgacataattggacaaactacct
acagagatttaaagctctaaggtaaatataaaatttttaagtgtataatgtgttaaactactgattctaattgttgtggtattttagattc
caacctatggaacttatgaatgggagcagtggtggaatgcctttaatgaggaaaacctgttttgctcagaagaaatgccatctagtg
atgatgaggctactgctgactctcaacattctactcctccaaaaaagaagagaaaggtagaagaccccaaggactttccttcagaat
tggtaagttttttgagtcatgctgtgtttagtaatagaactcttgcttgctttgctatttacaccacaaaggaaaaagctgcactgctat
acaagaaaattatggaaaaatatttgatgtatagtgccttgactagagatcataatcagccataccacatttgtagaggttttacttgc
tttaaaaaacctcccacacctccccctgaacctgaaacataaaatgaatgcaattgttgttgttaacttgtttattgcagcttataatgg
ttacaaataaagcaatagcatcacaaatttcacaaataaagcatttttatcactgcattctagttgtggtttgtccaaactcatcaatgt
atcttatcatgtctggatcccgccatggtatcaacgccatatttctatttacagtagggacctcttcgttgtgtaggtaccgctgtattcc
tagggaaatagtagaggcaccttgaactgtctgcatcagccatatagcccccgctgttcgacttacaaacacaggcacagtactgac
aaacccatacacctcctctgaaatacccatagttgctagggctgtctccgaactcattacaccctaccaagtgagagctgtaatttcg
cgatcaagggcagcgagggcttctccagataaaatagcttctgccgagagtcccgtaagggtagacacttcagctaatccctcgat
gaggtctactagaatagtcagtgcggctcccattttgaaaattcacttacttgatcagcttcagaagatgggcgagggcctccaacac
agtaattttcctcccgactcttaaaatagaaaatgtcaagtcagttaaggaggaagtggactaactgacgcagctggccgtgcgaca
tcctcttttaattagttgctaggcaacgccctccagagggcgtgtggttttgcaagaggaagcaaaagcctctccacccaggcctaga
atgtttccacccaatcattactatgacaacagctgttttttttagtattaagcagaggccggggacccctgggcccgcttactctggag
aaaaagaagagaggcattgtagaggcttccagaggcaacttgtcaaaacaggactgcttctatttctgtcacactgtctggccctgt
cacaaggtccagcacctccataccccctttaataagcagtttgggaacgggtgcgggtcttactccgcccatcccgcccctaactccg
cccagttccgcccattctccgccccatggctgactaattttttttatttatgcagaggccgaggccgcctcggcctctgagctattccag
aagtagtgaggaggcttttttggaggcctaggcttttgcaaaaagctaattc  
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